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Summary 
The purpose of this research has been to synthesise some 
new compounds which are useful standards in the identification 
of naturally occurring steroids of unknown structure. 
The work has been divided into three parts, the synthesis 
of 11- oxygenated counterparts of the 3R hydroxy- A5 steroids which 
have already been found in the processed urine of newborn infants, 
the synthesis of 15,17 -disubstituted 313 hydroxy- !,5 steroids and 
the synthesis of 313,18- dihydroxyandrost- 5- en- 17-one and 3R- 
hydroxy -18 nor- 13a- androst- 5 -en -17 -one. 
The synthesis of the 11- oxygenated counterparts of the known 
313- hydroxy- .65 steroids has involved the development of an efficient 
method for converting the 3-keto-z4 structure into the 3G- hydroxy - 
A5 system. This has been achieved by the reaction of the con- 
jugated enone with strong base in dimethylsulphoxide and the 
quenching of this reaction mixture with aqueous methanolic 
borohydride solution. The preparation from adrenosterone of 3R, 
16a- dihydroxyandrost-5-ene- 11,17 -dione and the corresponding 
1113- alcohol is described. 
The route to 313 hydroxy- A5 steroids from the sapogenin 
derivative 313, 1213 -diacetoxy- 25R,S- spirost- 5 -en -11-one has been 
used to synthesise 313,16a- dihydroxypregn- 5-ene- 11,20 -dione and 
313,21- diacetoxypregn- 5 -ene- 11,20 -dione. 
In the synthesis of 15,17 -disubstituted steroids suitably 
protected 114 compounds were prepared via the intermediate 
15 
p -17- ketone and the action of diborane on these compounds was 
investigated. 3ß,15a,17ß -Trihydroxyandrost -5 -ene was prepared 
in a 1:1 mixture with 3(3,15 ß,17ß- trihydroxy- 143 -androst- 5 -ene. 
33,15, 173- Trihydroxyandrost -5 -ene has been synthesised by way 
of the intermediate 15ß benz.yloxy -17 -keto compound. 
The synthesis of 3ß hydroxy- A5 steroids substituted at the 
0 -18 position has been investigated. 33- Acetoxy- 18- hydroxypregn- 
5-en-20-one hemiacetal has been prepared from pregnenolone by the 
'hypoiodite' reaction. This intermediate was used to synthesise 
38,18- dihydroxyandrost- 5 -en -17 -one. 
3R- Hydroxy -18- nor -13a- androst- 5- en- 17-one has been prepared 
by the sublimation of 33,18- dihydroxyandrost- 5 -en -17 -one at 2300. 
The 13u- configuration of the isolated product has been deduced by 
optical rotatory dispersion studies. 
Nomenclature 
In general, steroids are referred to by their full names, 

















Androst -4 -ene -3,11,17 -trione 
Androst -4- ene -3,17 -done 
110,17a,21 -trihydroxypregn -4- ene -3,20 -dione 
17x,21- dihydroxypregn -4- ene -3,1l,20- trione 
3R- hydroxycholest -5 -ene 
3ß- hydroxyandrost- 5- en- 17 -one 
3- hydroxyestra -1,3,5(10) -tríen- 17 -one 
3ß hydroxypregn- 5- en- 20 -one 
3ß hydroxypregna- 5,16 -dien- 20 -one 
pregn -4- ene -3,20 -dione 
17ß hydroxyandrost- 4- en -3 -one 
3a- hydroxy- 5p- androstan- l7 -one 
3ß- hydroxy- 20`a,22,25R- spirost- 5- en- l2 -one 
3ß- hydroxy- 20a,22e,25S- spirost- 5- en- 12 -one 
3ß- hydroxy- 20a,22a,25R- spirost -5 -ene 
Summary .. .. 
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INTRODUCTION 
The metabolism of steroids in the foetus and newborn infant 
1 
has attracted much recent research and of the many facts so far 
revealed, one of the most important is that in the foetus 
a relative deficiency of 3G hydroxy steroid dehydrogenase 
This is the enzyme system which (possibly in conjunction 
A4'5 isomerase) transforms the 3p- hydroxy- A5 grouping 






is an essential step in the in vivo synthesis of the important 
steroidal hormones such as progesterone and cortisol, from 
cholesterol and pregnenolone. The low activity of this enzyme 
system means that many of the important steroidal metabolites of 
the foetus have the 3ß hydroxy L system. 
After birth, 3ß- hydroxy - A5 steroids continue to play an 
important role in the newborn infant's steroid metabolism. As 
well as the presence in relatively large quantities of steroids 
still having the 3ß- hydroxy- Q5 structure, there is evidence for 
the continued presence of the enzyme system responsible for 16a- 
hydroxylation. These features of the newborn infant's metabolism 
are responsible for the relatively large proportion of 3p- hydroxy- 
6, 5 steroids and 16a- hydroxylated steroids excreted by the infant 
for the first few days after birth. 
Immediately after birth, changes in the infant's steroid 
metabolism occur and the pattern of excreted steroids changes 
,.rkedly. 5 In 1965 Eberlein showed that the concentration of 
2 
3ß hydroxy- A5 steroids in infant blood rose after birth to 200- 
600 ug. /100 ml.; this high level was maintained for about six 
days and fell to a very low level by the fiftieth day of life. 
The activity of the 16a- hydroxylating enzyme is considerably 
reduced by the sixth month of life,6 but for the first few weeks 
after birth the two most abundant steroids isolated from newborn 
infant's urine are 3ß,16a -dihydroxyandrost- 5 -en -17 -one and 3R,16a- 
dihydroxypregn-5-en-20-one.7 
Although much has already been discovered about the metabolism 
of steroids in the newborn infant, the analysis of 3R- hydroxy- 5 
steroids in processed urine from newborn infants has shown the 
presence of steroids which cannot yet be identified. The identi- 
fication of these steroids is difficult because of the small 
amounts of material which can conveniently be isolated. The main 
analytical techniques in use are as follows: 
1. Thin layer chromatographic comparisons, usually associated 
with specific colour stains. 
2. Gas- liquid chromatographic comparisons of both the free 
steroids and as methyl oxime and trimethylsilyl ether 
derivatives formed for protection of the steroids and 
for the greater resolution that these derivatives show 
during gas chromatography. 
3 The mass spectrographic analysis of steroids and their 
derivatives which is frequently combined with prior gas 
chromatographic separation of the components of a mixture. 
4. Infrared and ultraviolet spectroscopy of the steroids 
isolated by thin layer and gas chromatography. 
5. Various specific colour reactions for the indication of 
functional groupings. 
For all of the above techniques standards are desirable and any 
positive identification of a steroid would be difficult and 
possibly uncertain without the independently synthesised standard. 
From the use of the available techniques it is apparent that 
several of the unidentified steroids have the 3R- hydroxy- p5 
structure.8 These steroids exhibit characteristic colour stains 
when the compounds separated by thin layer chromatography are 
sprayed with a saturated solution of antimony trichloride in 
chloroform on the thin layer plate. The assignation of 3R- hydroxy- 
L,5 structure is also supported by mass spectral data and the lack 
of strong u.v. absorption by the unidentified steroids. A further 
difficulty encountered in the research into the steroid metabolism 
of newborn infants has been the limited availability of 30- 
hydroxy- 6, 5 standards. The object of this thesis is to present 
the partial synthesis of some 3p- hydroxy- a compounds which might 
be useful standards for this investigation. Routes to 3p- 
hydroxy- a5 steroids from readily available 3 -keto- 04 compounds 
have been investigated, together with routes to 3p- hydroxy -a 5 
steroids substituted at positions 11,15,16 or 18. The Jyhthesis 
of 3p- hydroxy- l8- r' -13a- androst- 5 -en -17 -one is described; this 
steroid could occur as an artefact if 18- hydroxy dehydroepiandro - 
sterone was present and was treated with base, as is the normal 
practice for the removal of phenolic steroids from the mixtures 
derived from urine. The occurrence of 18 -nor oestrone as an 
artefact in the identification of 18- hydroxy oestrone has previously 
been described.10 
The interest in positions 18 and 15 has been aroused because 
of the detection of 18 and 15 hydroxylated oestrogens in human 
pregnancy urine. 
10,11,12,13 
Just as 16a- hydroxy dehydroepiandros- 
terone is probably the precursor of the 1, -.rge amount of oestriol 
generated during pregnancy, 
1 
it has been thought possible that 
15- hydroxy and 18- hydroxy dehydroepiandrosterones might be 
precursors of the correspondingly substituted oestrogens. 
Recently it was suggested that 18- hydroxy dehydroepiandrosterone 
should be searched for in human cord blood. 
12 
The Characterisation of 3p- Hydroxy- 4a 5 steroids by Physical Methods 
Infrared Spectroscopy 
Hirschman14 has studied a large range of 3R- hydroxy- 6 5 steroids 
paying particular attention to common features in their infrared 
-1 
spectra, which are notably twin peaks in the 800 -807 cm. region. 
These twin peaks vary in relative intensity with substitution else- 
where in the molecule and have been assigned14'15 to the out of 
plane deformation of the 6- hydrogen. The observed frequencies 
for the corresponding 3ß- acetates lie in the range 800 -812 cm71 
These sets of twin peaks have however limited diagnostic value due 
to their low intensities, but it is notable that in the infrared 
spectra of the three 3R- acetoxy- 11 -oxo d5 steroids whose preparation 
is described here, (3R- acetoxyandrost- 5 --ene- 11,17- dione, 313,17- 
diacetoxyandrost -5,16 -dien -ll -one and 3p- acetoxy -l6a- bromoandrost- 
5 -ene- 11,17- dione), only one characteristic medium intensity peak 
in the region 817 -820 cm 71 is observed, both for solution (CS2) 
and nujol mull spectra. 
Nuclear Magnetic Resonance Spectroscopy 
The proton magnetic resonance spectra of 3p- hydroxy and 3R- 
acetoxy -p5 steroids measured in deuteriochloroform exhibit 
characteristic multiplets due to the hydrogen at the 6 position; 
these multiplets are centred between T4.55 and 4.65. When the 
5a,6ß -dichloro derivative is made the multiplet is again observed, 
now due to the 6a- hydrogen atom, and is then characteristically 
centred between T 5.55 and 5.65. From examples presented later 
it has become apparent that the partial contribution for the 
transition 3p- acetoxy- Q5 to 3p- acetoxy -5a,60- dichloro is 
0.02 }0.02 ¿for the C -18- methyl and -0.35+0.02Vfor the 0 -19- methyl 
group. This characteristic shift in the methyl frequencies on 
chlorination has proved to be useful in assigning the C -18 and 
0 -19- methyl signals where a compound and its corresponding 
dichloride have been made. 
For the polyhydroxylated steroids prepared in this work, 
deuteriochloroform was not suitable as a solvent due to the low 
solubility of the steroids. However,pyridine has proved a very 
useful solvent for studying the n.m.r. spectra of these poly - 
hydroxylated steroids. 
Mass Spectrographic analysis 
Most information from the mass spectra of 3p- hydroxy- 45 
steroids can be obtained by converting the free alcohol into the 
corresponding trimethylsilyl ether. The 3R- trimethylsilyloxy 
compound has a characteristic fragmentation pattern with a strong 
peak at m/e 129,16 this is frequently the strongest peak in the 
spectrum. This peak with mass /charge ratio 129 has recently 
17 
been proved by Djerassi to be due to a fragment derived from 
carbon atoms 1, 2 and 3 of the steroid skeleton together with the 
trimethylsiloxy group. Although it has been shown that the m/e 
129 peak can arise from groups other than the LS 5- 3p- trimethy l- 
silyloxy structure 17 18 the intense m/e 129 peak is characteristic 
of the 3p- hydroxy- L15 derivative. The formation of a fully 
trimethylsilanised derivative of a poly- alcohol also allows the 
number of hydroxyl groups in the molecule to be counted by obser- 
ving the molecular weight shown by the mass peak, and by the 
presence of m -90, m -180 and m -270 peaks which for example would 
appear in the spectrum of a triol derivative. 
Thin Layer Chromatography 
The thin layer chromatography of 3R- hydroxy -65 steroids has 
been extensively studied by Lisboa.19 Lisboa's systems were used 
throughout this work and the staining reagent used was a saturated 
solution of antimony trichloride in chloroform. With this reagent 
both 3ß hydroxy- 05 steroids and their acetates give rise to bright 
pink spots on the thin layer plates. Where a 7a- or 7ß- hydroxyl 
substituent is present a very intense blue -green colour appears 
without heating of the plate. When an 1lß- hydroxyl or a 14a- 
hydroxyl group is present the normal pink colour is tinged with 
blue to an extent which varies with the nature of the substituent. 
The 5a,6ß -dichloro group together with a 3R hydroxyl gives rise to 
a bronze colour when the steroid is stained with antimony trichloride. 
Gas Liquid Chromatography 
The 3ß hydroxy -A5 system is quite stable to the gas chromato- 
graphic conditions used in this work. The chromatography was 
carried out on a Perkin Elmer model 801; all glass columns packed 
with 22% E301 on Chromosorb G were used, with a gas flow of 33 ml. 
of helium per minute. The injector temperature was 250 °, the 
column temperature 24C1°and the detector temperature 240 °. On- 
column injections of solutions were made with a Hamilton syringe. 
A flame ionisation detector was used throughout. When the 5a,6p- 
dichloro grouping was used to protect the 5,6- double bond, the 
resulting intermediates could not be analysed by g.l.c. as the 
dichloride grouping is not stable to the high temperatures 
involved. 
3ß- Hydroxy- Q 4 systems are unstable when chromatographed at 
240 °20 but the diene peak which appears due to dehydration has 
been useful in determining some impurity concentrations in the 
work described later. 
The Stability of the 3ß- Eydroxy- 4.5 system Towards Various 
Reaction Conditions 
Oxidising Conditions. The hydroxyl function at C -3 in the 3R- 
hydroxy- 05 system can be adequately protected through most 
oxidation reactions by the formation of the 3R- acetate, the 5,6- 
unsaturation has also to be protected against many oxidising 
agents. In particular, protection is required against per - 
acids,21 chromic anhydride in acetic acid22 and also against 
conditions where allylic oxidation at C -7 can occur.23 Oxidation 
with lead tetraacetate is better effected with a protected 5,6- 
double bond,24 but in the case of oxidation of a 21 ° -17- acetate 
by this reagent, the unwanted side reaction at O5 does not appear 
to be serious.24 For all the above oxidations, protection of 
the double bond with 5a and 6ß- halogens has proved satisfactory. 
The 5a,6P- dichloro group has proved particularly stable and 
consequently particularly useful in this synthetic work, and the 
parent double bond can easily be regenerated by treatment of the 
dichloride with zinc powder in acetic acid. 
21 
The 5a,6P- dichloro group can easily be introduced into the 
steroid nucleus by adding sulphuryl chloride to a cooled solution 
of a 21 5 steroid in pyridine.25 Sulphuryl chloride reacts with 
pyridine to give a sulphur dioxide- pyridine complex and chlorine; 
the chlorine thus generated can react with any unsaturation in 
the usual manner. The advantages of the sulphuryl chloride - 
pyridine chlorination over the straight chlorination with chlorine 
gas is firstly that a weighed amount of sulphuryl chloride and hence 
- 10 - 
a weighed amount of chlorine may be used. The second advantage 
is that the pyridine serves a second function of removing any 
hydrogen chloride which might be formed in the reaction. Should 
hydrogen chloride be present, it might catalyse chlorination of 
a methylene group alpha to a ketone. 
One disadvantage of using pyridine, is that the formation of 
pyridinium salts with the steroid halide26 and with chlorine27 
occur as side reactions. Previous workers27 using chlorine and 
pyridine as a chlorinating agent have found that a pyridine : 
steroid ratio of 0.5 : 1 has given the best yields of addition 
product. However, in the work presented here the best conditions 
proved to be the use of a 10% solution of pyridine in benzene as 
the solvent, the sulphuryl chloride being added as an approximately 
5% solution in dry benzene. This sulphuryl chloride solution was 
stable over a period of one day and could be prepared as a standard 
solution by using a weighed amount of sulphuryl chloride. The 
reaction was performed in the presence of solid benzene which 
allowed a constant low temperature to be maintained during the 
reaction. 
The 5,6- dichlorides are much more convenient protecting groups 
than the 5,6- dibromides, which are difficult to crystallise27 and 
have been reported to mutarotate;28 moreover the dibromides are 
27 
much less stable to heat and to reducing and alkaline conditions. 
Halogenation of the 5,6- double bond can be achieved in the 
presence of a conjugated enone elsewhere in the molecule. 
Previously such a selective reaction has been reported as a 
oromination to protect the 5,6- double bond through an ailylic 
bromination at C-15 in 3p-acetoxy-5a,6ß-dibromopregn-l6-en-20- 
one.29 
Selective peroxidation of an unhindered double bond with an 
organic peracid in the presence of a 5,6- double bond is generally 
unsuccessful. The literature supports this contention both 
categorically27 and tacitly;24 in work described later in this 
thesis, attempts to selectively oxidise the 15,16 -double bond in 
the presence of 5,6 unsaturation resulted in a X15 -5a,6a -oxide 
being the only separable product. Peroxidation of an enone with 
alkaline hydrogen peroxide may, on the other hand, be carried out 
30,31,32 
in the presence of a 5,6- double bond, this reaction has 
been used to prepare 16a- hydroxypregnenolone.32 Selective 
hydroxylation of an enone with potassium permanganate may also 
be carried out in the presence of a 5,6- double bond.33 
Introduction of a bromine atom in a position alpha to a 
17- ketone may be achieved by brominating the corresponding 
enolacetate; this bromination proceeds so rapidly that when one 
equivalent of bromine is added very little of the bromine reacts 
with any 5,6- unsaturation.34 Bromination alpha to a ketal is in 
some reaction sequences an alternative to the bromination of the 
ketone, in this work it was found that attempts to brominate alpha 
to a ketal using phenyltrimethylammonium bromide perbromide35 
and pyridinium hydrobromide perbromide brought about partial 
Bromination at 
5 
. However, in this case as in other cases of 
unwanted bromination at C -5 and C -6 the 5,6- diaxial bromines can 
36 be removed by treatment with sodium iodide followed by aqueous 
- 12 - 
sodium thiosulphate, this sequence leaves other isolated bromines 
untouched. 
Reducing Conditions 
The catalytic hydrogenation of the G5 bond is reported to be 
difficult when a 3p- alcohol group is present,37'38' although 
when the substituent atC -3 is an acetate, the reduction is easier.37 
Selective hydrogenations have been performed in the presence of 
the 5,6- double bond39 and it has recently been reported40 that 
when an homogeneous catalyst such as tris- (triphenylphosphine) - 
rhodium is used, the 5,6- unsaturation remains intact after two days. 
When the 5,6- double bond is protected with a 5a,6p- dichloro 
group, greater care has to be taken over reducing agents. This 
trans diaxial group is reported to be stable to sodium borohydride24 
but carbon- chlorine bonds in general are reported to be reduced 
by lithium aluminium hydride.41 The 5ä,6p- dichloro group is 
reported here to be unaffected by the conditions used for the 
internal generation of diborane, and this stability means that 
selective hydration of a double bond elsewhere in the molecule 
can be achieved. 
Alkaline Conditions 
The 3p hydroxy- 5 system is found to be unaffected by very 
strong basic conditions, and the only danger of unwanted reaction 
occurring under basic conditions is when molecular oxygen is 
present, since this can give rise to allylic substitution at 
C -7.23 
- 13 - 
The Availability of 3p hydroxy- Q5 Steroids for use as Starting 
Materials 
The most common steroid found in animals is cholesterol, 
which occurs in brain and spinal cord in large amounts and is 
probably the metabolic precursor of pregnenolone. Cholesterol 
is cheap and commercially available from animal sources for the 
partial synthesis of compounds with the cholestane side chain. 
Most other 3R- hydroxy -65 steroids available in commercial 
quantities are obtained from vegetable sources. Diosgenin is a 
spirostane obtained from plants of the Dioscorea family and this 
compound is possibly the most important vegetable source of 
steroids. The sapolenin side chain can be degraded by techniques 
originally developed by Marker42 to give dehydropregnenolone, 
which in turn can be easily transformed into dehydroepiandrosterone, 
pregnenolone or progesterone; progesterone is widely used as a 
substrate for microbiological hydroxylation at position 11 in 
modern syntheses of cortisone. Dehydroepiandrosterone , pregnenolone 
and dehydropregnenolone are all used for the synthesis of commer- 
cially useful steroids and as such they are cheaply and readily 
available; these steroids therefore represent the best starting 
materials for the synthesis of many 3R- hydroxy- A5 steroids. 
313- Hydroxy- A5 steroids oxygenated at C -11 are however not 
so readily available. Most 11- oxygenated steroids produced 
industrially incorporate the 11- oxygen by microbiological hydroxy- 
lation, and this is necessarily carried out with the 3- keto 
-o4 
structure in the molecule. 
- 14 - 
A convenient source of 3R- hydroxy- p,5 steroids substituted at 
position 11 is a mixture of botogenin and neobotogenin (3R- hydroxy- 
25R,S- spirost- 5- en -12- -one). The mixture of isomers at C -25 is 
normally used because of the difficulty of separation of the 
isomers and because this centre of asymmetry is lost when the 
side chain is degraded. The 12- ketone group can be transformed 
into an 11- ketone group by using standard methods used for cortisone 
synthesis. The sapogenin side chain can be removed by the 
procedure of Marker42 to give 3ß- hydroxypregna -5,16- diene- 11,20- 
dione which is in turn a useful intermediate for the introduction 
of substituents at 16, 17 and 21. Although a good source of 
botogenin and neobotogenin has been reported in Dioscorea spiculi- 
flora, supplies of this material seem to be 1.estricted. For the 
work described here a generous supply of 33,12G- diacetoxy- 25R,S- spirost 
-5 -en -1l -one was kindly donated by Glaxo Laboratories Ltd., Montrose. 
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Previous Partial S ntheses of 16 and 11- Substituted 313- hydroxy- 45 
Steroids which are possible Metabolites of the Newborn Infant. 
Many of the possible steroid metabolites of the newborn infant 
have been synthesised from 313- hydroxyandrost- 5 -en -17 -one and some 
of these compounds have been shown to be present in processed 
urine of infants. 
1 3R- Hydroxyandrost- 5 -en -17 -one can be trans- 
formed into 313, 1713 -dihydroxyandrost- 5- en- 16-one (5)44 by the 
reaction with isoamyl nitrite in the presence of strong base to 
give the a- oximino ketone (4), which is reduced by zinc in acetic 
acid to the required ketol (5). This ketol has been detected in 
the processed urine of infants.45 The ketol (5) may be reduced to 
the triol (7) with sodium borohydride. 
3ß,16a Dihydroxyandrost- 5 -en -17 -one (9) has been synthesised 
from 38- acetoxyandrost- 5 -en -17 -one (1)24 by the chlorination of the 
5,6- double bond followed by enolacetylation of the dichloride (2) 
to give a 
16 
-17- acetate (3). Oxidation of the enolacetate with 
peracid and subsequent acid catalysed rearrangement of the oxide 
(6) gives 33,16a- diacetoxy- 5a,68- dichloroandrostan -17 -one which can 
be hydrolysed and dechlorinated to give the required ketol (9). 
This ketol can be reduced to give 3R,16a,178- trihydroxyandrost -5- 
ene (8). A newer synthesis of the ketol (9) has been reported by 
Hassner and Catsoulacos46 proceeding via the 16a- bromo-17- ketone 
(10). This a- bromoketone is reacted with sodium methoxide in 
methanol to give 3R,16a- dihydroxy- 17,17 -dimethoxyandrost -5 -ene (11) 
which can then be hydrolysed to give 38,16a- dihydroxy androst -5- 
en -17 -one (9). 
H 
PREVIOUS SYNTHESES OF 16a- OXYGENATED i)NaIVATIVES OF 
3 (3 -HYDRO XYPRE GN-5-EN-20-0NE 
- 16 - 
16a- Hydroxypregnenolone acetate (16) has been synthesised 
from dehydropregnenolone (12) by selective formation of the 16a,17a- 
32 
oxide (13) and reduction of this with chromous acetate. A 
separate synthesis of the 16a- hydroxy -20- ketone proceeded via 
33- acetoxy- 16a- benzyloxypregn- 5 -en -20 -one (14)47 this benzyloxy 
steroid is obtained by the base catalysed addition of benzyl 
alcohol across the enone in 3p- acetoxypregna -5,16 -dien -20 -one. 
The 16a- benzyloxy group may then be selectively hydrogenolysed 
using a palladium on charcoal catalyst, to give 16a-hydroxypreg- 
nenolone acetate. 30,16a,17a- Trihydroxypregn- 5 -en -20 -one (15) 
has been prepared by two different procedures. Dehydropregnenolone 
acetate (12) may be selectively hydroxylated at positions 16 and 17 
by reaction with one mole of potassium pe.rmanganate.33 Alterna- 
tively the 16a,17a -oxide of dehydropregnenolone (13) may be 
prepared and this reacted with hydrazine carbonic ester sulphate 
solution (NH2NH.0O2Et /H2SO4) to give 3(3,16a,170- trihydroxypre gn -5- 
en -20 -one (15)'49 This trihydroxy ketone may be converted into 
16a- hydroxydehydroepiandrosterone (9)33.by acetylation at C -16, 
reduction of the 20- ketone and cleavage of the glycol with 
periodic acid. 
Most of the 11- oxygenated dehydroepiandrosterone derivatives 
have been prepared from botogenin. Rothman and Wall have reported 
the synthesis of 3ß- acetoxyandrost- 5 -ene- 11,17 -dione (30),50 which 
was obtained by the standard degradation of the side chain of 
botogenin followed by further side chain degradation via the 20_ 
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readily rearranges, and the product can be hydrolysed to give 
3ß- acetoxyandrost- 5 -ene- 11,17 -dione (30). 
3P- Acetoxy androst- 5- ene- 11, -17 -dione was first reported by 
Martin- Smith51 as a dehydration product of the corresponding 5a- 
hydroxy compound (29). The properties of the compound described 
by Martin -Smith agree with the properties of the compound derived 
from botogenin. 
The rearranged oxime (26) serves as a good protecting group 
for the potential 17- ketone and the ketone at C -11 can be reduced 
in the presence of this unsaturated amide. Subsequent hydrolysis 
gives the 1p- hydroxy-17- ketone (27). 
Rothman and Wall and Djerassi31 have published separate 
routes from botogenin to cortisone by elaborating in the standard 
ways the intermediates 3ß- acetoxypregna- 5,16 -diene- 11,20 -dione (18) and 
3ß,11a -diacetoxypregna -5,16 -dien -20 -one which are obtained from the 
degradation of botogenin. The routes from botogenin to cortisone 
as published do not use 3ß,17a,21- trihydroxypregn- 5 -ene- 11,20 -dione 
as an intermediate but in a patent to the U.S. Department of 
Agriculture52 Rothman and Wall report the preparation of 21- acetoxy- 
3P,17a- dihydroxypregn- 5 -ene- 11,20 -dione (21). This material is 
the 3R- hydroxy- v5 analogue of cortisone acetate. 
Interest in the preparation of cholesterol from cholest -4- 
en -3 -one stimulated research into ways of converting 3 -keto- a4 
compounds into the corresponding 3ß- hydroxy- 05 steroids. The 
conversion in the case of cholesterol was required in order to 
obtain cholesterol labelled at the 4 position. Cholest- 4 -en -3- 
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and recyclising. Cholestenone was converted into cholesterol 
by Dauben and Eastham53 who formed the dienol acetate of choles- 
tenone and subjected this derivative to hydrolysis and in situ 
reduction with sodium borohydride in aqueous methanol. This 
deconjugation of the 3 -keto- 6,4 system has been used subsequently 
in the preparation of other 3ß- hydroxy - L\5 steroids. 
Adrenosterone (androst- 4 -ene- 3,11,17- trione) ,(has been con- 
verted into 3ß,14, 1713- trihydroxyandrost- 5 -ene54 by the deconjuga- 
tion and reduction route of Dauben and Eastham. This triol (32) 
can be selectively acetylated at positions 3 and 17, this allows 
subsequent oxidation at the 11 position to give the diacetoxy 
ketone (34). 
The 313 hydroxy -L counterpart of cortisone (21) has been 
synthesised by Fukushima and Teller.55 These workers prepared 
30- acetoxy- l4,170,21- trihydroxypregna -3,5- dien -20 -one bismethyl- 
enedioxy ketal (23) which was hydrolysed and reduced to the 3ß, 
1lß -diol (20) with the sidechain still protected as the bis- 
methylenedioxy derivative. This molecule can be selectively 
acetylated at position 3, oxidised and fully hydrolysed to give 
the cortisone analogue (21) LR° H). 
Pregnenolone with a 14C at position 4 has been synthesised 
from the corresponding progesterone,56 in this case the 20- ketone 
group was protected as the semicarbazone, which was introduced 
after the enone had been enolacetylated. 
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The Synthesis of 16 and 11 Oxygenated 30- Hydroxy- 05 Compounds 
The most convenient source of 3R- hydroxy- 11 -oxo Z compounds 
is the mixture of botogenin (3ß- hydroxy- 20a,22a,25R- spirost -5 -en- 
12-one) and neobotogenin (33- hydroxy- 20a,22a,25S- spirost- 5- en -12- 
one) obtained together from Dioscorea spiculiflora. These 12- 
keto sapogenins can be readily converted to 3ß- acetoxypregna- 
5,16- diene- 11,20 -dione (18),5° an ideá.1 intermediate for the 
preparation of most of the 11 and 16 disubstituted androstenes 
required. However, the limited availability of either the 
original sapogenins or any processed material stimulated research 
into the conversion of 3 keto- A4 compounds into 30- hydroxy- 45 
compounds. A generous gift of some 3ß,12ß-diacetoxy- 25R,S- 
spirost- 5 -en -12 -one (49) from Glaxo Laboratories Ltd., (Montrose), 
enabled some syntheses to be executed starting from the 11 -keto 
dehydropregnenolone derivative. These syntheses were confined 
to the pregnenes because here the intermediate was most useful. 
The substituted androstenes were synthesised from adrenosterone. 
The Conversion of Adrenosterone to 3ß- Hydroxyandrost- 5- ene- 11,17- 
dione 
The only previously successful method of converting 3 -keto- 44 
compounds into their 33- hydroxy - 6,5 counterparts has depended on 
the hydrolysis and the in situ reduction of the 3,5- dienol acetate. 
In this combined reaction it is obviously the hydrolysis which 
under these conditions is the difficult stage, because the 3 -keto- 05 
intermediate is readily reducedÇ39)' The result of a lengthy 
hydrolysis (about twenty -four hours at room temperature) is that 
- 20 - 
any other group in the molecule must be able to withstand the 
extended contact with the reducing agent. In most previous uses 
of this hydrolysis and reduction procedure there have not been 
other functional groups to reduce,53,55,56 but where such other 
reduction was possible this has been allowed to proceed.54 
Selective reductions have been achieved which leave an 11- 
ketone group intact,39 but the 11 -keto group is at least partly 
reduced after reaction with sodium borohydride for twenty -four 
hours with this reagent, whereas a 17- carbonyl group is quite 
quickly reduced. The problem therefore in the preparation of 
3ß- hydroxyandrost -5- ene -11,17 -dione is the preservation of the 11- 
and l7- ketone functions through the reaction. For the 17- ketone, 
a ketal would suffice for protection but the 11- ketone group is 
very difficult to ketalise.39 
The 17- ethyleneketal of adrenosterone was prepared (a dis- 
cussion of this synthesis will follow later) and this ketal was 
subjected to the borohydride hydrolysis and reduction reaction of 
Dauben and Eastham.53 The result of this reaction was that after 
twenty -four hours only 60;ú of the 11-ketone remained unreduced 
together with 11% of unreauced enolacetate. This route did not 
therefore appear promising and consequently an alternative reaction 
was sought which would allow rapid reduction of a40-3-ketone 
system and leave the 11- ketone untouched. 
The possibility of hydrolysing another derivative of the 
44 -3 ketone to give a 3ß hydroxy- 45 compound was considered. 
The other derivatives of the conjugated enone which are formed with 
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an accompanying shift of the double bond to the B -ring are the 
enamines, the dienol ethers, and the eth leneketal. Since the 
A5 -3- ketone is readily isomerised in the presence of acids,57 
only alkaline hydrolysis of these groups can be considered, and 
this means that the ethylene ketal derivative is of no further 
interest since this derivative is stable to base. 
The only dienol ether which might be of use was the trimethyl- 
silyl enol ether which would be expected to hydrolyse very readily. 
However, attempts to prepare this ether were unsuccessful. Bis- 
(trimethylsilyl)- acetamide being itself an enol ether is a very 
reactive silanising agent,58and it was thought that if triethyl- 
amine was used as a solvent, this might produce sufficient steroid 
enol to be transetherified. However, when a solution of 
testosterone in bis- (trimethylsilyl)acetamide and triethylamine 
was refluxed, only the l7ß- trimethylsilyl ether of testosterone 
could be isolated from the reaction mixture. 
The possibility of hydrolysing an enamine under mildly basic 
conditions seemed reasonable. Previous methods of obtaining 
6 5 -3- ketones have subjected these compounds to aqueous ammonia 
during the work -up procedure59 therefore the isomerisation of 
04 to 65 in the presence of this base is obviously slow. The 
enamine of adrenosterone was prepared and this compound was 
hydrolysed with aqueous ammonia to give a product which was indeed 
mainly the deconjugated enone androst- 5 -ene- 3,l1,17 -trione. 
U.v. analysis of the crude semicrystalline mixture isolated from 
the hydrolysis reaction showed that there was approximately 70% 
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of the unconjugated and 30% of the conjugated isomeric enone 
present. 
From the crude mixture of the conjugated and the deconjugated 
isomers, pure androst- 5 -ene- 3,11,17 -trione was isolated by column 
chromatography on Florisil.' The yield of isolated deconjugated 
material was low due to the difficulty of separation and to further 
isomerisation taking place on the column. The deconjugated enone 
was reduced to give 3R, l7ß -dihydroxyandrost- 5- en- 11-one but 
selective reduction of the 3- ketone over the 17 ketone was found 
not to be possible. Selective acetylation of the 3ß- hydroxyl 
over the 17- hydroxyl was also not possible and consequently no 
differentiation between the 3 and the 17 position could be achieved. 
The logical next step was to apply the en'amine deconjugation 
route to 17- ethylenedioxyandrost- 4 -ene- 3,11- dione. Unfortunately, 
when the experiments were repeated using the identical conditions, 
the hydrolysis reaction appeared to be much slower for the 17- 
ketalised compound. After four hours of hydrolysis, original 
enamine remained and partial isomerisation to the conjugated enone 
had occurred as before, giving an approximately 1:1:1 mixture of 
original enamine, deconjugated ketone and conjugated ketone. 
This route was therefore not a promising one for the synthesis of 
3ß- hydroxyandrost- 5-ene- 11,17 -trione. Experiments on the 
hydrolysis of testosterone enamine produced results similar to 
those with the ketal of adrenosterone. Thus it would appear that 
the speed of hydrolysis of these 3,5- dienamines depends largely 
on the nature of the other substituents in the molecule. 
The dienamines of 4,4 -3- ketones are reduced to tertiary amines 
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by sodium borohydride60 and therefore there is no possibility of 
effecting an hydrolysis in the -presence of borohydride and reducing 
the deconjugated enone in situ. 
No stable derivative of adrenosterone seemed suitable for 
the conversion to 3ß hydroxyandrost- 5 -ene- 11,17 -dione and therefore 
attention was focussed on the preparation of the 3 -keto- A5 system 
by direct deconjugation with strong base. 
Previous preparations of the 3- keto -A5 system have been 
reported which have used solutions of strong base to convert the 
enone to the thermodynamically favoured 3,5- dienolate anion. 
Ringold and Malhotra61,62 have studied this enolisation and in a 
series of papers have reported high concentration of the 3,5- 
dienolate anion. In the preparation of 3-keto-A 5 compounds these 
authors quench the dienolate anion solution with acetic acid to 
give the deconjugated ketone by protonation at C -4. 
In the deconjugation of 411'4- dien -3 -ones, Shapiro et al. °3 
have reported the preparation of A 1'5dien -3 -ones; these compounds 
have been isolated and reduced with aqueous borohydride solution. 
Shapiro and coworkers treated the cross conjugated dienorie with 
strong bases in dimethylsulphoxide, however, they did not quench 
the reaction mixture with acetic acid but poured the mixture into 
iced water which consequently became alkaline due to addition of 
the base. The high concentration of trienolate anion produced 
during the deconjugation must therefore have been protonated by 
the aqueous alkaline solution during the quenching. However, this 
reaction is more likely than the alternative one in which a high 
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quenching, since this would have involved protonation of the 
trienolate anion bÿ the aprotic alkaline solution used for this 
deconjugation. 
The deconjugated 4 l'5- dienones of Shapiro are more stable 
than the &5 -3- ketones because the 3- ketone remains conjugated to 
1 Q and this extra stability allows a better isolation of the 
2N 1'5- compound. This deconjugation of 1,4- dien -3 -ones might 
represent a route to the 3R hydroxyandrost -5 -enes since the unsaturatiLn 
at position 1 can be readily removed by homogeneous catalytic hydro - 
64 
genation. The starting material (androsta -1,4- diene -3,11,17 -trione) 
is commercially available, however a more convenient route to 3ß- 
h.ydroxyandrost- 5 -ene- 11,17 -dione was developed. Previous authors 
have commented on the variable concentrations of the thermodynamically 
more stable anion and also on the variable amounts.. of the deconjugated 
ketones which are present after quenching. These variations seem 
to be dependant in some uncertain way on the other functional groups 
present in the molecules, and these observations seem to be born out 
in the following deconjugation experiments. 
k solution of 17- ethylenedioxyandrost- 4 -ene- 3,11 -dione (40) in 
dry dimethylsulphoxide w treated with potassium tertiary butoxide 
under nitrogen to generate a large amount of the enolate anion (39). 
This solution was poured into a stirred solution of sodium boro- 
hydride in aqueous methanol. The 215- ketone (38) which must have 
been produced initially was rapidly reduced to the 3ß- hydroxy -Q 5 
e1,63 
compound (41), however the reaction time (ten minutes) was such 
that the amount of reduction of the 24--3- ketone present, was small 
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and that of the 11- ketone negligible. Gas liquid chromatographic 
analysis of the reaction product, isolated by an ether extr action, 
demonstrated the presence of 4ó of 3p- hydroxy- Q4 compound (43, 
R = (X. This reduced enone was analysed as its p3'5 -diene 
derivative2° which is produced quantitatively during gas chromato- 
graphy. Subsequent column chromatography of the product gave an 
8% return of unreduced d 4 -3- ketone (40); further column fractions 
contained 17- ethylenedioxy- 3ß- hydroxyandrost- 5 -en -11-one (41), which 
after crystallisation firstly from acetone -petrol and secondly from 
aqueous methanol represented a 70L yield of pure 45 -3ß- alcohol. 
In order to prove the position of the double bond in the 
reduced enone, the starting material, 17- ethylenedioxyandrost- 4 -ene- 
3,11 -dione (40) was reduced with borohydride, the melting point of 
the 17- ethylenedioxy -3 ß- hydroxyandro st- 4 -en -ll -one (43, R =<:]) 
produced, differed markedly from that of the deconjugated and reduced 
compound (41). Further evidence of the 3p- hydroxy - Z 5 structure 
comes from the n.m.r. spectra (in pyridine) of the two isomers. 
The spectrum for the v,5 -3P- hydroxy compound exhibits strong 
absorptions at îi 9.12, 8.64 and 6.19 which correspond to the C -18 
and C -19 methyl groups and to the ethyleneketal protons respectively, 
there is also a characteristic multiplet centred at 4.61 due to 
the hydrogen on C -6. The spectrum of the L isomer shows similar 
absorptions for the methyl and ketal protons, but the absorption 
at ¿ 4.61 has disappeared and two peaks at 7'4.25 and 2 4.36 are 
present; these absorptions are tentatively assigned to the (4 -!-í) 
and the 3- hydroxy proton. 
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Further proof of the identity of the 3p- hydroxy- ,L5 compound 
was obtained by the hydrolysis of the ketal and acetylation of the 
3p- alcohol to give the known 3p- acetoxyandrost- 5- ene -1l,l7 -dione (30), 
the material obtained from the deconjugation route was identical in 
all respects with material obtained by an independent route. 
o5 
By the route outlined above, 3phydroxyandrost- 5 -ene- 11,17-dione 
(42) may be synthesised from the readily available androst- 4 -ene- 
3,11,17-trione (28) in an overall yield of 45. The intermediates 
in this route provide a convenient synthetic pathway not only to 
3ß- hydroxy- ß5 compounds but also to 3p- hydroxy -,n.4 compounds which 
possess a ketone group at C -17. Such compounds have been made 
previously by indirect routes. ï.îorrealbb has recently published 
a route to 3ß- hydroxyandrost- 4 -ene- 11,17 -dione (43R4which involves 
the selective acetylation of a 3,17 -diol at position 3; this 
acetylation gives the desired monoacetate in only 9L yield and the 
overall yield to the required 11,17 -dione is considerably lower. 
Fukushima °7 has published a synthesis of 3p,11G- dihydroxyandrost - 
4 -en -17 -one which starts from cortisol and introduces the 17- ketone 
by periodate oxidation of the side chain. The key intermediate in 
the work presented above which allows the conversion to 3R- hydroxy- 
v,4 structure and the ready reintroduction of the 17- ketone is 
the 17- monoketal of androst- 4 -ene- 3,11,17- trione. 
68 
A previous synthesis of the 17- monoketal of androst- 4 -ene- 
3,17 -dione used one equivalent of ethyleneglycol and a limited 
amount of p- toluenesulphonic acid catalyst. This method required 
the chromatographic separation of the products and the best yield 
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of 17- monoketal was only 25% after crystallisation. Although 
the process could presumably be applied to androst-4-ene- 3,11,17- 
trione a more efficient route was sought. 
The -3- ketone will readily form an enamine with pyrrolidine6q 
and using one mole of the amine, reaction can be confined to the 
enone in the presence of other saturated ketones.70 Enamines have 
previously been transformed to their iminium salts to protect then 
through lithium aluminium hydride reductions; since the iminium 
salts are necessarily formed in the presence of anhydrous strong 
acid, it would seem probable that they are stable to these con- 
ditions and it was thought that these salts might be a good 
protection of the enone group through a ketalisation at the 17 
position. 
The iminium salt of 3-(N-pyrrolidyl)- androsta -3,5- diene- 11,17- 
dione (36) was prepared and because this was a salt, it was readily 
soluble in ethyleneglycol; this meant it was ideally suited to 
the ketalisation procedure of Campbell et a1.71 The salt was 
dissolved in ethyleneglycol and L- toluenesulphonic acid was added, 
the solvent was then distilled off vere slowly at about 600 under 
high vacuum. Any water formed as a result of formation of ketal 
was quickly removed under these conditions and therefore formation 
of the ketal was favoured. When the ketalisation was complete 
(after about two hours) aqueous ammonia was added to regenerate 
the enamine and the steroid was isolated with an ether extraction. 
The regenerated enamine was unstable to the conditions of the work - 
up and the product that was isolated in 72 yield after crystallisation 
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was 17- ethylenedioxyandrost- 4 -ene- 3,11 -dione (40). 
The synthesis of 17-ethylenedioxy-3ß-hydroxyandrost-5-en-11- 
one has allowed an alternative synthesis of 3R,14- dihydroxyandrost- 
5 -en -17 -one (27) which has been previously synthesised by Rothman 
and Wall from botogenin50 and by Meystre from cortisone.72 The 
latter synthesis is reported in a. patent, but the physical con- 
stants of the 3p- hydroxy- 05 compounds prepared by Dr. C. Meystre 
have been kindly supplied by Dr. R. Neher.73 
In order to check on the general applicability of the base 
deconjugation procedure,the reaction was applied to other suitable 
p -3- ketones namely testosterone and adrenosterone. In both 
these cases the reaction did not proceed as well as in the case 
of the monoethyleneketal of adrenosterone and it was found 
necessary to acetylate the products from these reactions to 
simplify the isolation procedure, even so the yields of the cor- 
responding 2S 5- 33- acetates were only moderate. In the case of 
testosterone the product isolated after acetylation was 3P,17- 
diacetoxyandrost -5 -ene in 4b;ß yield and in the case of adrenosterone 
the isolated product was 3P,17P- diacetoxyandrost- 5 -en -11-one (34) 
obtained in 16% yield. In both these cases the amounts of 
,e4 -3- ketones and v4 -3p- hydroxy compounds shown to be present 
were higher than in the case of the 17- ethylenedioxy compound (40). 
It seems likely in view of the previous evidence61,63 on the 
variable concentrations of the 3,5- dienolate anion in base decon- 
jugation mixtures that these lower yields of deconjugated ketones 












THE MECHAITISM OF REACTIOB! OF A 16a- BROMO- 17- ITONE WITH 
SODIUM ME]THOXIDE PROPOSED BY A.HASSFER AID P.CATSOULACOS 
OH 
-29- 
dienolate anions in the basic deconjugating medium before the 
quenching and reduction. 
The Synthesis of 3ß, 11ß ,16a- Trihydroxyandrost- 5 -en -17 -one and 
3R,16a- Dihydroxyandrost- 5 -ene- 11,17 -dione 
The efficient synthesis of 3ß- hydroxyandrost- 5 -ene- 11,17 -dione 
described above allowed the synthesis of 11,16 disubstituted 
androst -5 -enes. As has already been described two methods exist 
for the preparation of the 16a- hydroxy -17- ketone structure; the 
first, a longer route24 involves the protection of the 5,6- double 
bond and subsequent oxidation of the enolacetate (3) formed from 
the 17- ketone. The second synthesis involves the preparation of 
the 16a- bromo -l7- ketone, reaction of this with sodium methoxide 
in methanol to give a 16a -hy droxy- l7- dimethylketal and hydrolysis 
of the ketal to give the required 16a- hydroxy -17- ketone. The 
mechanism of this unusual reaction has been studied by Hassner 
and Catsoulacos46 and these authors have proposed the sequence 
illustrated. Their mechanism depends on an equilibrium between 
the 16a- and 16G bromo ketones and they postulate ß attack by the 
methoxy ion on the ß bromoketone. An oxide intermediate is 
formed and this opens prior to final attack by methoxide ion to 
give the stable hydroxy -ketal. 
The a -bromo ketone route has several advantages; it involves 
less intermediates, it is likely to proceed in a higher overall 
yield and the most important is that it provides an intermediate 
where the 17- ketone group is protected against lithium aluminium 
hydride reduction. This protected intermediate allows the 
OAc 












preparation of the corresponding 11p- hydroxy compound. The 
preparation of the 16a -bromo ketone, however, presented an initial 
problem; direct bromination with bromine would give 5,6- bromina- 
tion apart from the fact that the bromination of the 17- ketone 
group does not proceed smoothly74 Bromination of a 17- ketone 
with cuprous bromide proceeds in moderate yield (50) only .75 
Bromination of the enol acetate76 gives a good yield (77;x) of 
bromo ketone but this method requires the initial preparation of 
the enol- acetate. 
The enol -acetate (44) was prepared using acid catalysed exchange 
with isopropenyl acetate. This method which is very mild gave a 
clean product which could be isolated in yield. The bromina- 
tion of this enol -acetate in carbon tetrachloride with one mole of 
o 
bromine at -10 was virtually instantaneous. The product could be 
isolated in 7b yield, this was an overall yield of bromoketone (45) 
of 61%, which was reasonable considering the other functional groups 
present in the molecule. 
The bromo- ketone was reacted with sodium methoxide in methanol 
following the method of Hassner and Catsoulacos46 The yield of pure 
product (46) was 37. The yield in this reaction was lower than 
expected since the literature records a 65% yield for the 11- desoxy 
analogue. The mother liquors from the crystallisation were 
analysed by column chromatography but this did not achieve a good 
separation of the mixture, however a small amount of 3f3- hydroxy- 
androst -5 -en- 11,17 -dione (42) was finally isolated. Although the 
Lount of 3p- hydrox_androst- 5 -ene- 11,17 -dione isolated represents 
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only a proportion of the amount present, its presence does not 
allow the explanation of the low yield of the product (46) from 
the reaction. 
The hydroxy ketal (46) could be hydrolysed at 400 using 
p-toluene sulphonic acid in aqueous acetone, this method gave a 
good (80) yield of the ketone (47). This milder hydrolysis gave 
a better yield than that obtained by Hassner and Catsoulacos on 
the 11- desoxy compound for the hydrolysis of which a 65 yield was 
quoted. 
The dimethoxy ketal (46) was reduced with lithium aluminium 
hydride to give the 11p- alcohol, the acid hydrolysis of the work -up 
removed the ketal group to give 3p,11p,16a- trihydroxyandrost -5 -en- 
17 -one (48) in an overall yield of 36;' from the ketal (46). 
EXPERIMENTAL SECTION 
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Experimental Procedure.- Pelting points were determined on a 
Kofler hot stage apparatus and are corrected. 
Rotations were measured either on an L.T.L. -N.P.L. automatic 
polarimeter or on a Perkin Elmer polarimeter model 141, rotations 
were measured at 589 mia in chloroform unless otherwise stated. 
Optical Rotatory Dispersion curves were measured in methanol on 
a Bendix -Ericsson Polarmatic 62. Infra red spectra were 
recorded on a Unicam 8.2.200 or on a Perkin Elmer 237 instrument, 
spectra were usually for carbon disulphide solutions. Ultra- 
violet spectra were recorded on a Unicam 8.P.800 using ethanol 
solutions. Nuclear Magnetic Resonance spectra were obtained 
from a Perkin Elmer R10 (60mc /s) spectrometer using tetramethyl- 
silane as an internal standard; deuteriochloroform solutions 
were used unless otherwise stated. Gas- liquid Chromatography 
was done on a Perkin Elmer model 801 using 6 ft. all glass columns 
of 1/16" internal diameter. The stationary phase was 2á% 
silicone gum rubber E301 on Cromosorb G. Injector, column and 
detector temperatures were 250,240 and 2500 respectively. 
Relative retention times for both g.l.c. and t.l.c. are expressed 
relative to 3p- hydroxyandrost- 5 -en -17 -one (dehydroepiandrosterone) 
and are written as RD values. For thin layer chromatography 
Merck silica gel G was used throughout and the steroids were 
stained with saturated solutions of antimony trichloride in 
chloroform. The developing systems were those of Lisboa.19 
Mass spectrometry was carried out on an L.Ir.B.9000 instrument 
y Dr. C. J. +d. Brooks of Glasgow University. Trimethylsilyl 
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ethers were prepared by the method of Sweely et al.136 using 
pyridine, hexamethyldisilazane and trimethylchlorosilane in the 
proportions 7:2:1, the steroid solutions were then injected 
directly into the gas chromatographic columns. 
Alumina refers to Spence type H alumina of Brockman activity 
2. Florisil refers to a synthetic magnesia- silica gel adsorbent. 
Petrol refers to petroleum ether with boiling range 60 -800. 
Microanalyses were determined either by Drs. Veiller and Strauss 
of Oxford or by Bairds Ltd. of Edinburgh. 
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3- (N- Pyrrolidy1)- androsta -3,5- diene- 11,17 -dione (3ö) 
Pyrrolidine (1.90 g.) was added to a hot solution of androst- 
4 -ene- 3,11,17 -trione (28) (7.17 g.) in methanol (220 ml.) under a 
nitrogen atmosphere. The solution was allowed to cool slowly to 
room temperature. The crystals which formed were filtered off, 
washed with cold methanol and dried. The crystals decomposed 
above 185° (lit ?9 dec. abovè 180 °). max 1735, 1701 and 1634 
cm. 
- 
Yield 7.6 g. 
17- Ethylenedioxyandrost -4 -ene -3,11 -dione (40) 
3- (N- Pyrrolidyl)- androsta -3,5 -diene -11,17 -dione (7.5 g.) was 
dissolved in ether (100 ml.) and chloroform (100 ml.) dry hydrogen 
chloride was passed through the solution for 15 minutes. The 
steroid was extracted into water (150 m1.) and the aqueous solution 
was washed twice with 100 ml. portions of ether. The aqueous 
solution was evaporated to dryness leaving a glass (7.6 g.) which 
did not crystallise. N.m.r. (D20) showed one olefinic proton at 
`x3.58 and methyl resonances at 29.13 and 2 8.62. The non -crystalline 
imminium hydrochloride (37) (7.6 g.) and p- toluene sulphonic acid 
(500 mg.) were dissolved in ethylene glycol (150 ml.). The 
ethylene glycol solution was stirred and gently distilled at about 
0.01 mm. pressure keeping the temperature between 60 and 70 °. The 
distillation was continued for three hours after which time about 
5 ml. of liquid remained. The residue was dissolved in water (200 
ml.) and 80% ammonia (5 ml.) was added. The flocculent precipitate 
which formed was dissolved in ether (400 ml.) and the ethereal 
solution was washed with saturated salt solution, dried 
with 
- 3 5 - 
magnesium sulphate and evaporated to dryness. The crystalline 
residue was recrystallised from methanol to give 17- ethylene- 
dioxyandrost- 4 -ene- 3,11 -dione (40) (5.7 g.) m.p. 149 -151 °; 
[a]j) = 1-198° (c 0.1); y max 1701 and 1673 cm.;1 n.m.r. (CDC13) 
:c 9.15 (C -18 methyl), 8.54 (C -19 methyl) and °z 4.28 (4H). An 
analytical sample was recrystallised from methanol, m.p. 151 -152 °. 
(Found: C, 72.9; H, 8.1. C21H2804 requires C, 73.2; H, 8.2 %). 
3- Acetoxy -17- ethylenedioxyandrosta -3,5- Bien -11 -one. 
17 -Ethy lenedioxyandrost -4 -ene -3,11 -dione (40) (1.3 g.) was 
dissolved in redistilled ethyl acetate (50 ml.) and a solution of 
acetic anhydride (10 ml.) and 70% perchloric acid (0.02 ml.) in 
ethyl acetate (40 ml.) was added. The solution was allowed to 
stand at room temperature for five minutes then it was poured into 
dilute sodium carbonate solution. The mixture was shaken until 
evolution of gas had ceased then ether (500 ml.) was added, the 
ethereal solution was washed with sodium carbonate and saturated 
salt solution. The solution was dried with magnesium sulphate 
and evaporated to dryness. The residue was -recrystallised from 
aqueous methanol to give 3- acetoxy -l7- ethylenedioxyandrosta -3,5- 
dien -l1-one (0.9 g.) m.p. 153 -156 °; [alp -83° (c 0.1); y max 
-1 
1747, 1700 cm.; n.m.r. (CD'f3) 79.15 (C -18 methyl), 1'8.80 (C -19 
methyl), si 7.88 (3- acetate) and 4.65, 4.32 multiplets, (6H, 4H). 
(Found: C, 71.4; H, 7.9. C23H3005 requires 0, 71.5; H, 7.85). 
Hydrolysis and in situ reduction of 3- Acetoxy- 17- ethylenedioxy- 
andro sta -3 , 5- dien -ll -one . 
3- Acetoxy-17-ethylenedioxyandrosta-3,5- dien -1l -one (180 mg.) 
- 36 - 
was dissolved in 90% aqueous methanol (110 ml.) and sodium boro- 
hydride (55 mg.) was added. The mixture was stirred until the 
borohydride had dissolved and then maintained at 25o for 24 hours. 
Water was added and the steroid was recovered by an ether 
extraction. The ethereal solution was dried and evaporated to 
dryness. The infrared spectrum showed there to be approximately 
60% of the 11- ketone remaining (y max 1700 cm.l) and 10% of un- 
reacted enolacetate, (y max 1747 cm -1). 
Attempted Preparation of the _.fienolsilyl ether of Testosterone. 
I? S- Hydroxyandrost- 4 -enf -3 -one (0.5 g.) was dissolved in tri- 
ethylamine (25 ml.) and freshly prepared58 bis(trimethylsily1)- 
acetamide (5 ml.) was added and the solution was refluxed for two 
hours with the rigorous exclusion of moisture. After two hours 
the reaction mixture was poured into water and the steroid was 
extracted with ether, the ethereal solution was washed with water 
and saturated salt solution, dried with magnesium sulphate and 
evaporated to dryness. Infrared analysis of the product showed there 
to be strong enone absorption, this indicated that there could only 
be a very small amount of the required dienolsilyl ether. No 
absorption at 1700 cm. -1 was noticeable. 
Androst- 5 -ene- 3,11,17 -trione 
3-( N- Pyrrolidyl)- androsta- 3,5- diene- 11,17 -dione (36) (800 mg.) 
was dissolved in acetone (120 ml.), ammonium chloride (1 g.) 
dissolved in 40% aqueous ammonia (20 ml.) was added. The suspen- 
sion of ammonium chloride was stirred at room temperature for two 
- 37 - 
hours. Water (40 ml.) was added and the solution was evaporated 
to 40 ml. at room temperature, a crystalline precipitate formed and 
this was filtered off and dried. Yield 620 mg. The ultraviolet 
spectrum of this crude product had ),. max at 238 rot (c = 4500) 
indicating there to be 30% of the conjugated ketone remaining. The 
extinction coefficient for pure adrenosterone being 15,180 measured 
at 238 mt. The crude mixture was chromatographed on Florisil (100 
g.) Elution with ether gave androst- 5 -ene- 3,11,17 -trione (200 
mg.), further elution with ether -chloroform (1:1) gave mixed frac- 
tions containing both androst- 5 -ene- 3,11,17 -trione and the original 
androst- 4 -ene- 3,11,17 -trione, these mixed fractions were not 
crystallisable. The deconjugated enone was recrystallised from 
ethanol to give 100 mg. of pure androst- 5 -ene- 3,11,17 -trione. An 
analytical sample was recrystallised from ether, m.p. 170 -182 °, (the 
large melting point range is due to the ready isomerisation of p5 to 64) 
-1 
max (CHC13) 1740 and 1710 cm.; n.m.r. X9.11 (C18 methyl), 
78.60 (019 methyl), and T4.59 multiplet (6H). (Found: C, 76.2; 
H, 8.4. 019H2403 requires C, 76.0; H, 8.05 %). 
3p,17ß- Dihydroxyandrost- 5 -en -11-one (35) 
Androst- 5 -ene- 3,11,17- trione (100 mg.) was added to a stirred 
solution of sodium borokidride (100 mg.) in methanol (22 ml.) and 
water (2.5 ml.). The steroid dissolved and the solution was stirred 
for 30 minutes. Excess water was added and the steroid was extracted 
into ether. The ethereal solution was washed with dilute hydro- 
chloric acid, sodium carbonate and saturated salt solution and was 
evaporated to dryness to give a residue which was recrystallised 
- 38 - 
from aqueous methanol to give 3(3,170- dihydroxyandrost- 5 -en -11 -one 
(35) (50 mg.), m.p. 222 -224° (lit3 m.p. 230 -232 °) [a]D = -41° 
(c 0.1); n.m.r. (pyridine) _2 9.08 (C -18 methyl), 7.-8.60 (C- 19'methyl) 
and 2;4.55 multiplet (6H). 
3-( N- Pyrrolidy1)- 17- ethylenedioxyandrost-3,5- dien -1l -one. 
17- Ethylenedioxyandrost- 4 -ene- 3,11 -dione (1 g.) was dissolved 
in hot methanol (50 ml.) and pyrrolidine (0.5 ml.) was added. The 
solution was allowed to cool to room temperature and the enamine 
crystallised out. The crystals were filtered off and dried to 
give 3- (N- pyrrolidyl) -17- ethylenedioxyandrosta -3,5- Bien- 11-one (1 g., 
dec. above 175 °), which was not further purified. The infrared 
spectrum of the enamine showed no enone absorption in the 1660 cm. 
-1 
region. V 1699, 1635 cm.1 
Mild Hydrolysis of 3-(N-Pyrrolidyl)-17-ethylenedioxyandrosta-3,5- 
dien -1l -one. 
3-( N- Pyrrolidyl)- 17- ethylenedioxyandrosta-3,5- dien -11-one 
(300 mg.) was hydrolysed using the same reaction conditions as for 
the hydrolysis of adrenosterone enamine. The infrared spectrum 
of the hydrolysed product showed there to be approximately equal 
proportions of enamine J max,1635 cm., conjugated ketone (40) 
1675 cm. 
-1 and deconjugated ketone (38) 1703 cm 
71 
Mild Hydrolysis of the Enamine of Testosterone. 
l7ß- H, ydroxy- 3-( N- pyrrolidy1 )- androsta- 3,5- diene69 (850 mg.) 
was hydrolysed in the manner already described, but increasing the 
reaction time from two hours to eight hours. The infrared spectrum 
- 39 - 
of the crude product showed it to contain approximately equal 
amounts of the original enamine (P 1535 cm 71), conjugated 
ketone (testosterone, V max 1675 cm -1) and 17ß- hydroxyandrost -5- 
en-3-one, (V max 1703 em 
71). 
17- Ethylenedioxy -3ß hydroxyandrost- 5 -en -11 -one (41) 
17- Ethylenedioxyandrost- 4 -ene- 3,11 -dione (40 ) (4.2 g.) in 
dry dimethylsulphoxide (300 ml.) was stirred under nitrogen whilst 
potassium tert. -butoxide (12 g.) was added. The solution was 
stirred for two and a half hours then poured quickly into a stirred 
solution of sodium borohydride (1.9 g.) in methanol (270 ml.) and 
water (30 ml.). The reduction was allowed to continue for ten 
minutes then water (500 ml.) was added and the steroid was extracted 
into chloroform. The chloroform solution was washed with dilute 
hydrochloric acid, sodium carbonate solution, saturated salt solu- 
tion and dried with magnesium sulphate. The chloroform solution 
on evaporation to dryness yielded a residue which was chromatographed 
on alumina (150 g.). Elution with ether gave unchanged 17- ethylene- 
dioxyandrost- 4 -ene- 3,11 -dione (40) (0.5 g.) m.p. 150 -151° (from 
methanol); further elution with ether -chloroform (9:1) gave 
crystalline material (3.2 g.), which on recrystallisation from 
acetone -petrol and again from aqueous methanol gave 17- ethylenedioxy- 
3R- hydroxyandrost- 5 -en -1l -one (41) (2.9 g.) m.p. 150 -151 °. An 
analytical sample was recrystallised from methanol m.p. 150 -1510; 
[a]D -41° (c 0.1); ) max 1700 cm.l n.m.r. (pyridine) 
9.12 
(C18 methyl), T8.64 (C19 methyl), X6.19 ( ethyleneketal protons), 
14.01 multiplet (6H); (CDC13) `C 9.18, 8.81, 6.13 and 4.65. 
- 40 - 
(Found: C, 72.4; H, 8.4. C21H3004 requires C, 72.8; H, 
Gas- liquid chromatogrp.phy of the reaction product using helium 
carrier as (column temperature 240 °, flow rate 25 ml. /min.) 
showed a peak with a relative retention time with respect to 5a- 
cholestane of 0.59 ( 17- ethylenedioxyandrosta -3,5- dien -1l -one) and 
two further peaks not fully resolved of relative retention times 
1.03 and 1.22 (17- ethylenedioxy -3R- hydroxyandrost- 5 -en -1l -one and 
17- ethylenedioxyandrost- 4 -ene- 3,11 -dione respectively). The area 
under the diene peak was 4jö of the total area. 
17- Ethylenedioxy- 3ß- hydroxyandrost- 4 -en -11-one (43, R = <oJ) 
17- . thylenedioxyandrost-4-ene- 3,11 -dione (40) (440 mg.) was 
dissolved in methanol (45 ml.) and water (5 ml.), sodium borohydride 
(200 mg.) was added and the mixture was stirred for 15 minutes. 
Dilute hydrochloric acid was then added and the steroid extracted 
into chloroform. After the usual work up, this solution was 
evaporated to yield a residue which was crystallised from acetone - 
petrol (b.p. 100 -120 °) to give 17- ethylenedioxy- 3p- hydroxyandrost- 
4 -en -ll -one (240 mg.), m.p. 206 -209 °; [a]D =4-79° (o 0.1); 
-1 
V max (CH013) 1702 cm.; n.m.r. (pyridine) T9.11 018 methyl), 
78.63 (C19 methyl) 7 6.20 (4 ethyleneketal protons), X5.55 
multiplet (3aH), 4.36 and 4.25 (unassigned); (CDC13) Z 9.18, 
8.74, 6.14 and 4.66 (4H). An analytical sample was recrystallised 
from methanol, m.p. 208 -210 °. (Found: C, 72.8; H, 9.0. 
C21H3004 requires C, 72.8; H, 8.7). 
- 41 - 
3ß- Hydroxyandrost-- 4 -ene- 11,17-dione (43,R =0 
17- Ethylenedioxy -3f3- hydroxyandrost- 4 -en -11 -one (61 nib;.) was 
dissolved in acetone (30 ml.) and water (10 ml.). p- Toluene -- 
sulphonic acid (50 mg.) was added and the solution was kept at 
40° for twelve hours. The solution was evaporated to half its 
volume in vacuo and the steroid was extracted into chloroform. 
The chloroform solution was washed with sodium carbonate solution, 
saturated salt solution and was dried with magnesium sulphate. The 
solution was evaporated to dryness and the residue was recrystallised 
from hexane to give 3R- hydroxyandrost -4 -ene -11,17 -dione (37 mg.) 
66 
m.p. 167 -170° (lit. m.p. 172 -173 °) [a]D = +15° (c 0.1) V m4x1734 
and 1704 cm.l; n.m.r. (CDC13) 9.13 0-18 methyl), T 8.83 (C -19 
methyl) and r 4.14 multiplet (4H). 
3 -Hydroxyandrost -5 -ene -11,17 -dione (42) 
17_Ethylenedioxy -3p- hydroxyandrost -5- ene -11,17-dione (5.2 g.) 
was dissolved in acetone (400 ml.) and p- toluene - sulphonic acid 
(3 é.) in water (70 m1.) was added. The solution was refluxed for 
four hours. Water (200 ml.) was added and the solution was evapo- 
rated to half its volume. The steroid was extracted into chloroform 
and this solution was washed with sodium carbonateand saturated salt 
solution. After drying with magnesium sulphate the chloroform 
solution was evaporated to give a residue which was recrystallised 
from aqueous acetone to give 3- hydroxyandrost- 5 -ene- 11,17- dione, 
(4.3 ;.), rn.p. 221 -222 °; [a]D = +48° (c 0.1). (Lit.73 m.p. 217 -2190; 
-1 
[0-ID +57 + 4° (c 0.805) dioxan). U max (CHC13) 1704 and 1734 cm., 
n.m.r. (CD013) 7 9.14 (C -18 methyl), T 8.78 (C -19 methyl) and 4.55 
multiplet (6H). 
- 42 - 
3(3,17 (3 -Dihydroxyandrost- 5 -en -11 -one (35) from 30-hydroxyandrost- 
5 -et 11,17 -dione (42) 
3p- Hydroxyandrost-5-ene- 11,17 -dione (200 mg.) was reduced with 
sodium borohydride in aqueous methanol to give a product identical 
to that from the borohydride reduction of androst- 5 -ene- 3,11,17- trion( 
described above. 
3R- Acetoxyandrost- 5 -ene- 11,17 -dione (30) 
3ß- Hydroxyandrost -5- ene -11,17 -dione was acetylated using 
acetic anhydride and pyridine. The product was recrystallised 
from methanol, m.p. 175 -176 °, [al") +34° (c 0.1) (lit.5o m.p. 174- 
175°; lit.51 m.p. 170 -171.5 °; [a]D = +38° (c 2.1) dioxan). 
max 1738, 1706, 1240 and 819 cm.l; j) max(nujol) 1742, 1730, 1712, 
-1 
1240 and 817 cm. ; n.m.r. (CDC13) 9.14 (C -18 methyl), re 8.77 
(C -19 methyl), sr 7.97 (acetate) and ': 4.56 multiplet (6H). 
3ß, 11ß -Dihydroxyandrost- 5- en- 17-one (27) 
17- Lthylenedioxy- 313- hydroxy androst- 5 -en -17 -one (500 mg.) was 
dissolved in anhydrous ether (60 ml.) and lithium aluminium hydride 
(500 mg.) was added; the suspension was stirred for twelve hours 
at 20 o . After a conventional work up the infrared spectrum of 
-1 
the crude product showed appreciable absorption at 1740 cm. ; the 
hydrolysis of the ketal was therefore completed by dissolving the 
residue in acetone (150 ml.) and water (50 ml.) and adding con- 
centrated hydrochloric acid (5 ml.) and allowing the solution to 
stand for three hours. The steroid was recovered by chloroform 
extraction. Evaporation gave 3(3,11p- dihydroxyandrost- 5 -en -17 -one 
-43- 
which was recrystallised from methanol to give crystals (200 mg.) 
m.p. 191 -193° (lit.50 m.p. 190 -192 (3). 
Base Deconjugation of Adrenosterone and the in situ Reduction of 
the Deconjugated Enone. 
Androst- 4 -ene- 3,11,17 -trione (2 g.) was deconjugated by base 
and then reduced using the procedure already described for the 
deconjugation and reduction of the 17- ethylene ketal of adreno- 
sterone. The reaction product was chromatographed on alumina 
(150 g.). Elution with ether- chloroform (1:3) gave crystalline 
material (340 mg.) which on recrystallisation from petrol -acetone 
gave 17ß hydroxyandrost- 4-ene- 3,11 -dione (250 mg.) m.p. 178 -182° 
(lit.131 m.p. 183 -184 °). Further elution with chloroform- methanol 
(98:2) gave material (1.1 g.) which did not crystallise well, this 
material was acetylated with acetic anhydride- pyridine. The 
acetylated material was recrystallised from acetone -petrol and 
again from ethanol to give crystals of 3ß,l7ß- diacetoxyandrost -5- 
en-11-one (370 mg.) m.p. 166 -169° (lit.72 m.p. 173- 175 °). The 
infrared spectrum of this material was identical with authentic 
material 
5 
Gas liquid chromatography of the total product (column 
temperature 240 °, helium flow rate 25 ml. /min.) showed there to be 
16% of 3ß,17ß -dihydroxyandrost- 4 -en -11-one, which was analysed as 
the corresponding 3,5 -diene with relative retention time 0.41 that 
of 5a- cholestane. 
Base Deconjugation and Reduction of Testosterone. 
17ß- Hydroxyandrost- 4 -en -3 -one (4.5 g.) was deconjugated and 
reduced in the manner described above for adrenosterone. Infrared 
- 44 - 
analysis of the total reaction product showed there to be some 
conjugated ketone still present (p max 1673 cm -1). The product 
was chromatographed on alumina (200 g.); elution with ether - 
chloroform (4:1) gave crystalline material which on recrystallisation 
from acetone -petrol gave testosterone (650 mg.), m.p. and mixed m.p. 
147 -150 °. Further elution with ether -chloroform (1 :1) gave 
crystalline material which was acetylated with acetic anhydride 
pyridine and recrystallised from aqueous methanol to give 3ß,l7ß - 
deacetoxyandrost -5 -ene (2.2 g.) m.p. 157 -158° (lit.1,32 157 -157.5 °). 
Gas liquid chromatography of the total reaction product as above 
showed there to be 3ó of 343,17ß- dihydroxyandrost- 4 -ene, analysed as 
l7ß hydroxy androsta -3,5 -diene with a relative retention time of 0.31 
to 5a.- cholestane. 
313,17- Diacetoxyandrosta- 5,16 -dien -l1-one (44).- 3ß- Hydroxyandrost- 
5 -ene- 11,17 -dione (42) (2.5 g.) and 2- toluenesulphonic acid (200 mg.) 
were dissolved in isopropenylacetate (30 ml.). The solution was 
refluxed through a short fractionating column so that the vapours 
were on the point of distilling over into a receiving condenser. 
With this arrangement any acetone formed was removed from the 
reaction flask. The constant slow distillation was continued for 
eight hours. The volume in the reaction flask was kept constant 
by the addition of fresh isopropenyl acetate; a total of 30 ml. 
of fresh isopropenyl acetate was added during the eight hours. 
When the reaction was complete the solution was evaporated to 15 
ml. and poured into sodium carbonate solution; the steroid was 
extracted into ether. The ethereal solution was washed with 
-45- 
further sodium carbonate solution and with saturated salt solution. 
The ethereal solution was dried with magnesium sulphate and 
e vaporated to dryness. The residue was recrystallised from ether - 
petrol to give 3p,l7- diacetoxyandrosta -5,16- dien- 117one (2.25 g.) 
m.p. 155 -161° [a]D = -13° (c 0.1); 9 max 1757, 1734, 1706, 1245, 
1204 and 822 cm.l; n.m.r. (CDC13) ¿ 9.13 (C -18 methyl), 7 8.78 
(C -19 methyl), 7 7.98 (acetate), 7 7.85 (enolacetate), 1. 4.57 
multiplet (6H) and 4.42 multiplet (16H). An analytical sample 
was recrystallised from hexane m.p. 159 -161° (Found: C, 71.1; 
H, 7.5. C23H3005 requires C, 71.5; H, 7.8%). 
3R- Acetoxy- 16m- bromoandrost- 5 -ene- 11,17 -dione (45).- 3 (3,17 -Di- 
acetoxyandrosta -5,16 -dien -ll -one (44) (2.5 g.) was dissolved in dry 
carbon tetrachloride (100 ml.) and the solution was cooled to -10 °. 
The solution was stirred while a solution of bromine (1.06 g., 
1.02 eq.) in carbon tetrachloride (13 ml.) was added over two 
minutes. The solution was stirred for a further two minutes then 
an aqueous solution of sodium bisulphite was added. The steroid 
was extracted into chloroform (100 ml.) and the chloroform solution 
was washed with sodium carbonate and saturated salt solution. The 
solution was dried with magnesium sulphate and evaporated to dryness. 
The residue was recrystallised from ethanol to give 3ß- acetoxy -16a- 
bromoandrost- 5 -ene- 11,17 -dione (2.1 g.) m.p. 182 -185°; [alp +370, 
(c 0.1); 
l) max 1760, 1738, 
1714, 1241 and 814 cm.l; n.m.r. (CDC13) 
T9.10 (C -18 methyl), 178.77 (C -19 methyl), 2;7.97 (L..Jetate), X4.55 
multiplet (6H), I' 5.37 multiplet (16ßH). An analytical sample was 
recrystallised from ethanol, m.p. 183 -185 °. (Found: C, 60.1; 
- 46 - 
H, 6.0; Br, 18.1. C21H2704 Br requires C, 59.7; H, 
Br, 18.9i') . 0 
3ß, 16a- Dihydroxy- 17,17 -dimethoxyandrost- 5 -en -11-one (46).- 
3ß- Acetoxy -l6a- bromoandrost- 5 -ene- 11,17 -dione (45) (1.9 g.) in hot 
methanol (80 ml.) was added to a solution of sodium methoxide in 
hot methanol (50 ml.) formed by the dissolution of sodium (2 g.) 
in the methanol. The solution was refluxed for one hour then 
poured into cold water (300 ml.). The steroid was extracted with 
ether and the ethereal solution was successively washed with dilute 
hydrochloric acid, sodium carbonate solution and saturated salt 
solution. The ethereal solution was dried with magnesium sulphate 
and evaporated to dryness. The residue was recrystallised from 
ether to give 3ß,16a- dihydroxy- 17,17- dimethoxyandrost- 5 -en -11-one 
(0.6 g.) m.p. 168 -174 °; [a]D -68° (c 0.1); V max (CHC13) 1704, 
1170, 1112 and 1055 cm.l; n.m.r. (CDC13) Z 9.26 (C -18 methyl), 
8.81 (C -19 methyl), ir 6.65, 6.59 (methoxy protons) and/T-4.66 
multiplet (6H). An analytical sample was recrystallised from ether 
m.p. 172 -176 °. (Found: C, 68.7; II, 9.14. C21H3205 requires 
C, 69.2; H, 8.9%). Chromatography of the mother liquors on 
alumina gave crystalline material which was recrystallised from 
ether to give 3phydroxyandrost- 5 -ene- 11,17-dione (42) (45 mg.), 
identified by infrared and n.m.r. spectroscopy and an undepressed 
mixed melting point with authentic 3ß- hydroxyandrost- 5- ene- 11,17- 
dione. 
3ß,16a -Dihydroxyandrost- 5 -ene- 11,17 -dione (47).- 3p,16a-Dihydroxy- 
17,17- dimethoxyandrost- 5 -en -ll -one (46) (240 mg.) was dissolved in 
- 47 - 
acetone (50 ml.) and a solution of £- toluene- sulphonic acid (200 
mg.) in water (5 ml.) was added. The solution was kept at 40° for 
twelve hours then water (10 ml.) was added and the solution 
evaporated in vacuo to a half its volume. The steroid was 
extracted with chloroform. The chloroform solution was washed 
with sodium carbonate solution and with saturated salt solution. 
The solution was dried with magnesium sulphate and evaporated to 
dryness. The residue was recrystallised from acetone -petrol to 
give 3(3,16a- dihydroxyandrost -5- ene -11,17 -elione (170 mg.) m.p. 204- 
210°. A further recrystallisation from aqueous acetone gave 
material m.p. 209 -212° [a]l) +81 °, (c 0.1) V max (nujol) 1755, 
and 1690 cm.l; n.m.r. (pyridine) ~ 9.12 (C -18 methyl), 8.66 
(C -19 methyl), 5.30 multiplet (16ßH), multiplet (6H). 
An analytical sample was recrystallised from aqueous acetone,m.p. 
209 -212 °. (Found: C, 70.2; H, 8.3. 
requires C, 70.2; H, 8.6%). 
C19H2604' CH3.00.CH3, 
3ß, 11ß, 16a -Trihydroxyandrost- 5- en- 17-one (48).- 3R,16ä- Dihydroxy- 
17, 17- dimethoxyandrost- 5 -en -ll -one (46) (320 mg.) was dissolved in 
ether (100 ml.) and lithium aluminium hydride (500 mg.) was added, 
the solution was refluxed for two hours. The excess lithium 
aluminium hydride was decomposed with ethyl acetate and then dilute 
hydrochloric acid was added. The acidified material was allowed 
to stand for two hours. Fresh ether (300 ml.) was added and the 
ethereal solution was washed with sodium carbonate solution followed 
by saturated salt solution. The solution was dried with magnesium 
sulphate and evaporated to dryness. The residue was recrystallised 
- 48 - 
from acetone -petrol and again from aqueous acetone to give 3ß,11ß, 
16c trihydroxyandrost- 5 -en -17 -one (48) (100 mg.) m.p. 209 -212 °; 
[a]D +8° (c 0.1) F max.(nujol) 1745 cm:l; n.m.r. (pyridine) 
7 8.56 (C -18 methyl), T8.38 (0 -19 methyl), broad multiplet 26.05 
(3c1,H) , 5 5.31 multiplet (16ßH) , Z 4.66 multiplet (6H) , 'Y'4.5 doub- 
let (11aH). An analytical sample was recrystallised from aqueous 
methanol m.p. 209 -212 °. (Found: 0, 68.1; H, 9.1. C19H2804 




THE SYNTHESIS OF SOME I)Ì RIVATIVES OF 11- KETO- PREGEENOLONE 
( 5 5 ) 
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The Synthesis of 3p,16o, Dihydroxypregn -5 -ene -11,20 -dione and 
3p,21- Diacetoxypregn- 5 -ene- 11,20 -dione from Sapogenins 
The starting material for these syntheses was 33,123-diacetoxy- 
25R, S- spirost- 5 -en -12 -one (49) , a gift from Glaxo Ltd., Montrose. 
This material was treated with calcium in liquid ammonia to remove 
the 12- acetoxy group. The reductive cleavage of the 12p- acetoxy 
77 
group is reportedly accompanied by only small loss of the 3p- 
acetoxy group, though partial hydrolysis of this group occurs and 
reacetylation is necessary. This method was an adaption of that 
of Chapman et a177 altered to suit the solubility of the sapogenin. 
The 3p- acetoxy- 25R,S- spirost- 5 -en -11-one was subjected to a 
modification of the Marker degradation42 to remove the spirostane 
side chain. The best yields were obtained by omitting a crystal- 
lisation of the intermediate epimeric 3Ç- acetoxy- 25R,S- spirost -5- 
en- 11-oae since it would not crystallise -well. No attempts were 
made to isolate any of the intermediates in the degradation of the 
spirostane side chain. The crude side chain degradation product 
was then chromatographed on alumina. The removal of the side 
chain also removed the epimeric nature of the material and pure 
3P- acetoxypregna -5,l6 -diene -11,20 -dione (18) was obtained in 24 
overall yield from the l2 ß- acetoxy sapogenin (49) . 
The methods of synthesising the 16a- hydroxy -20- ketone 
structure were investigated. A trial rection involving the 
addition of benzyl alcohol across the eneone system was carried 
out on a small scale. Alumina chromatography of the product 
gave unchanged starting material but no other crystalline material 
- 50 - 
was obtainable. The hydrogenolysis of the benzyl group in the 
presence of the 20- ketone and the 4,5 moiety was almost certain 
to prove difficult and consequently an alternative route was sought. 
The chromous ion has been reported to reduce the lea,l7a- oxido -20- 
ketone to the 16a- hydroxy -20- ketone in poor to moderate yield,32 
but the product having an extra hydroxyl group is easily separable 
by column chromatography. Unfortunately the 16a- hydroxy -20- ketone 
is sensitive to acids and the use of chromous chloride leads to 
considerable dehydration to the original enone. Chromous acetate 
is therefore used but since chromous acetate is rather insoluble 
in most organic solvents, long reaction times are essential. 
3 P- Hydroxy -16cß, l7a- oxidopre gn- 5- ene -ll, 20 -dione (52) was prepared 
by increasing the time of the alkaline peroxidation of the 21 lb 
compound (18) to allow complete hydrolysis of the 3G- acetate. 
This oxide was reacted with freshly prepared chromous acetate in 
a sealed vessel for 16 hours. The product was chromatographed on 
Florisil and recrystallised to give a 16L yield of 3p,16a-dihydroxy- 
pregn- 5 -ene- 11,20 -dione (55). The identity of this material was 
confirmed by infrared spectroscopy, the absence of strong u.v. 
absorption, the increased polarity of the product and its n.m.r. 
spectrum. The n.m.r. spectrum in pyridine showed the disappearance 
of the oxide signal at '6.19 and the appearance of a one hydrogen 
multiplet at 'f5.0 due to the l6 p- hydrogen. 
Turning to the synthesis 3G,21-diacetoxypregn-5-ene-11,20- 
dione (54), a model reaction in the 11- desoxy series was the intro- 
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duction of the 21- acetoxy group into dehydropregnenolone acetate 
- 51 - 
The only really satisfactory method for the introduction of the 
21- acetate has been that of Djerassi,79 and this method involving 
the 21 -iodo compound has been followed here in the 11 -keto series. 
The dienol acetate (50) was prepared by the established 
method,78 the perchloric acid catalysed reaction with acetic 
anhydride in ethyl acetate has been reported not to acetylate the 
A16- 20- ketone,$0 although results with the 04- 3- ketone are 
excellent. The enolacetate was treated with freshly prepared N- 
iodosuccinimide81 in dioxan and the resulting iodo ketone (51) was 
not isolated but treated directly with potassium acetate in acetone. 
The resulting 21- acetoxy compound (53) was obtained in an overall 
yield of 51á from 33,20- diacetoxypregna -5 ,16,20 -trien- 11-one (50). 
The hydrogenation of the enone (53) produced an unexpected 
difficulty, when the enone was hydrogenated using a 10% palladium 
on charcoal catalyst one mole of hydrogen was rapidly taken up, 
but the steroid isolated was non crystalline and presumably a 
mixture of the 17m- and 173- isomers. However, when the catalyst 
was changed to tris(triphenyl)phosphine rhodium,40 the homogeneous 
catalytic hydrogenation proceeded over the space of 22 hours to 
give pure 33,21- diacetoxypregn- 5 -ene- 11,20 -dione (54) in a 50% 
yield. The 173 configuration of the side chain is expected 
from consideration of the reaction involving the corresponding 
compound without 11 and 21 functional groups.40 The 173 configura- 
tion is also supported by n.m.r. evidence, the frequencies of the 
methyl signals agree with those calculated from additive values, 
82 
the calculation below uses the values of Zurcher. 





5a,14c-androstane 9.208 .` 9.308 
3ß-acetoxy -0.017 0.000 
L\ 5 -0.233 -0.042 
11-keto -0.217 +0.033 
17ß-00.CH201.1c +0.008 +0.042 
8.749 ti 9.341 
The observed frequencies of absorption 
of the methyl groups in 3p, 21- diacetoxy- 




For general Experimental =Procedure see page 32 
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3ß- hcetoxy- 25R,S_sp irost- 5 -en -11 -one (17).- 3p,12G- Diacetoxy- 
25R,S- spirost- 5 -en -11 -one (49) (20 g.) was dissolved in toluene 
(150 ml.) and solvent (25 ml.) was distilled off at atmospheric 
pressure. Calcium granules (5.8 g.) were added to anhydrous 
liquid ammonia (i litre) and the solution was stirred for five 
minutes to allow the metal to dissolve. The steroid solution 
in toluene was allowed to cool to room temperature and it was then 
added dropwise to the stirred solution of ammonia over a period of 
ten minutes. The solution was stirred for a further thirteen 
minutes then a solution of bromobenzene (4.8 ml.) in toluene (25 
ml.) was added cautiously over four minutes, the solution was 
stirred until all calcium had disappeared. Water (180 ml.) was 
cautiously added over a period of 20 minutes and the excess ammonia 
was then evaporated off and the residue acidified with hydrochloric 
acid. The steroid was extracted into ether (1 litre) and the 
ethereal solution was washed with sodium carbonate solution and 
saturated salt solution. The ethereal solution was dried with 
magnesium sulphate and evaporated to dryness. The residue was 
dissolved in pyridine (50 ml.) and acetic anhydride (200 ml.) and 
this solution was allowed to stand for twelve hours. The excess 
reagent was evaporated off under reduced pressure and the residue 
was dissolved in ether, the ethereal solution was washed with 
dilute hydrochloric acid, sodium carbonate solution und saturated 
salt solution, dried with magnesium sulphate and evaporated to 
dryness. The crystalline residue was used directly in the side 
chain degradation procedure. 
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3p- Acetoxypregna -5,16- diene -11,20 -dione (18).- Crude 3G- acetoxy- 
25R,S- spirost -5 -en- L-one (17) (18 g. from the preceding experiment) 
was dissolved in acetic anhydride (l00 ml.) and pyridine (50 ml.) 
at 80 °, anhydrous methylamine hydrochloride (25 g.) was added and 
the mixture was refluxed for ten minutes. Solvent (about 10 ml.) 
was distilled off and the temperature of the reaction mixture rose 
to 155°, the solution was then refluxed at this temperature for 
four hours. The reaction mixture was cooled and poured into 
crushed ice (1 litre) and the ice was stirred periodically for 
one hour. The steroid was extracted into chloroform (1 litre), 
the chloroform solution was washed well with water and with 
saturated salt solution, dried with magnesium sulphate and 
evaporated in vacuo to remove the chloroform. The residue was 
dissolved in dichloromethane (400 ml.) and acetic acid (400 ml.), 
the solution was cooled to -5° in an ice -salt bath and was stirred 
while a solution of chromic anhydride (12.5 g.) in 90% aqueous 
acetic acid (400 ml.) was added, the temperature was kept below 
-2° during the addition. A solution of sodium bisulphite (30 g.) 
in water (200 ml.) was added with the temperature kept below 00; 
water (1 litre) was added and the steroid was extracted into ether 
(2 litres). The ethereal solution was washed well with water and 
with saturated salt solution, dried with magnesium sulphate and 
the ether was evaporated off in vacuo. Acetic acid (500 ml.) was 
added to the residue and the solution was refluxed for eight hours. 
The acetic acid was removed in vacuo and the residue was dissolved 
in petrol and benzene (7 :3), this solution was washed with sodium 
-55- 
carbonate and saturated salt solution and dried with magnesium 
sulphate. The petrol and benzene solution was placed on a column 
of alumina (400 g.), elution with ether gave non crystalline 
material, elution with ether /chloroform (19:1) gave crystalline 
material which was recrystallised from methanol to give 3P- 
acetoxypregna- 5,16 -diene- 11,20 -dione (18) (5.5 g.); m.p. 179 -183 °, 
(lit.30 m.p. 183 -186 °). 
3P- Hydroxy- 16a,17a- oxidopregn- 5 -ene- 11,20 -dione (52).- 3ß- Acetoxy- 
androsta -5,16 -diene- 11,20 -dione (18) (1 g.) was dissolved in 
methanol (60 ml.) and chloroform (10 ml.) and the solution was 
cooled to -5 °; 30 hydrogen peroxide (3 ml.) was added over a 
period of 5 minutes whilst maintaining the low temperature, this 
was followed by the addition of 2N.NaOH (3 ml.). After one hour 
the solution was allowed to warm to room temperature and was 
stirred at this temperature for twelve hours. 'Water (300 ml.) 
was added and the steroid was extracted into ether, the ether 
solution was washed with water then with ferrous sulphate until 
no further discoloration of the ferrous solution was noticed, the 
solution was then washed with water and saturated salt solution 
dried with magnesium sulphate and evaporated to dryness. The 
residue was recrystallised from aqueous acetone to give 3p- hydroxy- 
16a,17a- oxidoandrost- 5 -ene- 11,20 -dione (0.80 g.), m.p. 193-196°; 
[u.]p +17° (c, 0.1); max. Y (nujol) 
1693, 1050, 861 and 819 cm. 
n.iu.r. Z 8.98 (C -18 methyl), 8.81 (C -19 methyl), 7 7.98 (C -21 
methyl) , K6.19 (16(3H) , 4.65 multijlet (6H) . Found: C, 69.75; 
H, 8.6. C211-12804; H20 re,,iuires 0, 69.6; H, 8.3,'2. 
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3R,16a Dihydroxypre gn_5- ene -11,20 -dione (55).- 3R- Hydroxy -16a, 
17a- oxidopregn -5 -ene -11,20 -dione (52), (.88 g.) and sodium acetate 
(200 mg.) were dissolved in acetic acid (30 ml.) and freshly 
prepared moist chromous acetate (4 g.) was added; a magnetic 
stirring bar was introduced into the flask, the air was displaced 
with nitrogen and the flask was firmly stoppered. The contents 
of the flask were vigorously stirred for 16 hours, the solution 
was then poured into water and the steroid was extracted by two 
extractions with 150 ml. chloroform. 
were combined and washed with water, 
water and saturated salt solution. 
magnesium sulphate and evaporated to 
The chloroform solutions 
sodium carbonate solution, 
The solution was dried with 
dryness. The residue was 
analysed by t.l.c. analysis (20% ethanol in benzene, system H of 
Lisboa19), this showed 2 spots,the more polar spot was the minor 
one and was of a polarity compatible with the 16a hydroxylated 
material the polarity of the major component showed that it was 
probably the original oxide (52). The crude material was 
chromatographed on Florisil (60 g.) deactivated with 5% w/w of 
water. Elution with ether gave crystalline material which infra- 
red evidence showed to be mainly original oxide but to contain 
some LN 6 -20- ketone ( Y max1660 
cm.1) estimated to be about 20% 
of the total product. Further elution with chloroform- methanol 
(9:1) (200 mg.) this was recrystallised from acetone -petrol to 
give 3(3,16a- dihydroxypregn -5- ene -11,20 -dione (55) (140 mg.); 
m.p. 211 -213 °; [a]D +17° (c 0.1, dioxan); max(nujol) 1700, 1210, 
1169, 1062, 879 and 817 cm.1; n.m.r. (pyridine) 9.29 (0 -18 
- 57 - 
methyl), .ÿ 8.68 (C -19 methyl), 7 7.84 (C -21 methyl), ¿ 5.00 (160H) 
and 4.60 (6H). Found: C, 72.8; H, 8.7. 01H3004 requires 
C, 72.8; H, 8.7%. 
33,20- Diacetoxypregna- 5,16,20 -trien -1l -one (50).- 3ß-Acetoxypregna- 
5,16- diene- 11,20 -dione (18) (2 g.) and p- toluenesulphonic acid (100 
nig.) were dissolved in freshly distilled isopropenyl acetate (15 ml.) 
and the solution was refluxed for one hour. After this time 
gradual distillation was commenced with the temperature adjusted 
so that the solvent was on the point of being distilled from the 
reaction flask. This constant slow distillation was continued for 
ten hours. The solvent volume was maintained at 15 ml. by the 
addition of fresh isopropenyl acetate and a total of about 10 ml. 
of solvent was distilled off during the ten hours. The reaction 
mixture was cooled and poured into an aqueous sodium carbonate 
solution. The steroid was extracted into ether and the ethereal 
solution was washed with saturated salt solution, dried with 
magnesium sulphate and evaporated to dryness. The residue was 
recrystallised from ether to give 3ß,20-diacetoxypregna- 5,16,20- trien- 
140 -1$ 
11 -one (1.0 g.) m.p.J an analytical sample was recrystallised from 
methanol, m.p. 145 -150° [0.]D -26° (c, 0.1); j.) max.1757, 1730, 1700, 
1242, 1198, 1029, 959 and 817 cm71; n.m.r., 1' 9.06 (C -18 methyl), 
Y8.76 (C -19 methyl), 7.97 (3- acetate methyl), 7.82 (20- acetate 
methyl), 5.77 and 4.99 doublets J =2 c.p.s. (21- protons), c 4.56 
(6H), ands 4.11 (16H). Found: C, 72.7; H, 8.0. C25H3205 
requires C, 72.8; H, 8.0%. 
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3f,21- Diacetoxypregna- 5,1ó- diene- 11,20 -dione (53).- 3f,20- Diacetoxy- 
pregna -5.,16,20- tríen -11 -one (50) (.94 g.), dry dioxan (2 ml.) and 
freshly prepared N- iodosuccinimide81 (.63 g. m.p. 200 -205 °) were 
placed in a 50 ml. round bottomed flask, the air was displaced 
with nitrogen and the flask was sealed firmly. The sealed flask 
was warmed at 85° for one hour then hot methanol (5 ml.) and hot 
10% aqueous potassium iodide solution (1 ml.) were added. This 
mixture was stirred for two minutes then 20¡ aqueous thiosulphate 
solution was slowly added until precipitation of steroid was 
complete, the crystalline material which had been precipitated was 
filtered of washed with water and dried. The crystalline product 
3p- acetoxy -2l- iodopregna -5,1 ó -diene- 11,20 -dione (51) (810 mg., 
max. 243 6-8,100) was not purified further but was used 
directly for the next stage in the reaction. This crude product 
(750 mg.) was dissolved in acetone (50 ml.). Potassium hydrogen 
carbonate (6 g.) and acetic acid (3.2 ml.) were ground together 
and the resulting paste was added to the solution of steroid in 
acetone. The slurry was stirred and refluxed for ló hours. 
Water was added and the reaction mixture was evaporated in vacuo 
to remove most of the acetone. The crystals which formed during this 
l9 J 
evaporationLfiltered off and recrystallised from aqueous acetone 
to give 3f,21- diacetoxypregna- 5,16 -diene -11,20 -dione (460 mg.) m.p. 
170 -172 °; [a]D -25° (c, 0.1); k max.236 m E -9020; P)max(nujol) 
-1 
1761, 1729, 1700, 1682, 1592, 1240, 1220, 828 and 816 cm. ; n.m.r. 
G 9.09 (0 -18 methyl), 8.79 (0 -19 methyl),I: 
8.00 (3- acetate methyl), 
7.86 (21- acetate methyl), 5.06 (21- methylene), 4.59 (6H), 
- 59- 
-3.17 (16H). Found: 0, 70.0; H, 7.7. C H 0 requires 25 32 6 
C, 70.1; H, 7.5%. 
Hydrogenation of 3ß,2l- Diacetoxypregna -5,16- diene- 11,20 -dione with 
10% palladium on Charcoal.- 3ß,21- Diacetoxypregna- 5,16- diene -11, 
20 -dione (53) (50 mg.) was hydrogenated in a Clauson -Kaas and 
Limborg130 microhydrogenation apparatus using benzene as solvent 
(3 ml.). 10% Palladium on charcoal (5 mg.) was added to the 
benzene solvent and the catalyst was prehydrogenated, the steroid 
was then added to the system. 1.05 Equivalents of hydrogen were 
rapidly taken up and the hydrogen uptake ceased after 30 minutes. 
The solution was filtered and the filtrate was evaporated to dry- 
ness to give a non crystalline glass. Chromatography of the 
product on alumina (10 g.) produced no crystalline material. T.l.c. 
analysis showed one pink spot. 
Hydrogenation with a homogeneous catalyst.- The above hydrogenation 
was repeated using tris(triphenylphosphine)rhodium (7 mg.) as the 
catalyst. The steroid (50 mg.) was hydrogenated for 30 hours 
after which time only very slow hydrogen uptake was noticeable. 
The solution was removed from the hydrogenation apparatus and was 
allowed to stand in an open vessel overnight, the solution was then 
passed down a column of alumina (20 g.) and the column was eluted 
with ether. The total eluate was evaporated to dryness in vacuo. 
The residue crystallised and was recrystallised from aqueous acetone 
to give 3ß,21- diacetoxypregn -5 -ene -11,20 -dione (54) (25 mg.), m.p. 
118 -120 °; [a]D +30° (c, 0.1); / max.(CS2) 1752, 1730, 1706, 1240, 
- 60 - 
1228, 1038 and 817 cm71; n.m.r. 9.34 (0 -18 methyl), 8.79 (C -19 
methyl), E 7.97 (3- acetate methyl), í 7.84 (21- acetate methyl), 
5.45 (21- methylene) and ¿4.64 multiplet (6H). Found: C, 69.4; 
H, 8.2. C25H3406 requires C, 69.7; H, 8.0%. 
The Synthesis of 15,17- Disubstituted 3p- Hydroxy androst -5 -enes 
The main aim of this work has been the preparation of the 15a- 
and 15ß hydroxy derivatives of 3R- hydroxyandrost- 5 -en -17 -one 
(dehydroepiandrosterone) and 3R,17ß- dihydroxy androst- 5 -ene. In 
these preparations the difficulty lies not only in the preparation 
of the D -ring structure but also in carrying out the synthesis in 
the presence of the 3R- hydroxy- 45 structure. However the main 
problem is the inaccessibility of the 15 position. 
The chemical preparation of 15 substituted steroids fall into 
three important classes; transformations of naturally occurring 
15 substituted material, transformations on the 14,15- double bond 
and reactions of p 5 -17- ketones. The first class is severely 
restricted by the non -availability of the naturally occurring 
15 substituted compounds. The only synthesis of interest is that 
of 15 -keto progesterone from digitogenin.96 The applicability of 
the reactions in the other two classes to the syntheses required 
here will be discussed in detail. 
The transformations of the 14,15- double bond have been mainly 
concerned with cardiac aglycones. Most of these aglycones have a 
14 substituent as well as the distinctive side chain, the 14 
substituent (usually a R- hydroxyl group) lends itself to ready 
dehydration. The transformations of the 14,15 -double bond in 
this series are not generally applicable to the androstanes. The 
most important discrepancy between the two series, is the con- 
figuration of the oxides obtained in peroxidation of the double 
bond; in general peroxidation with peracid is a in the cardanolides 
and pregnanes83,84,85anla 
R in the androstanes.86 The preparation 
gav;zs 
of L compounds in the androstanekhas been difficult and 
consequently little chemistry has been done on these compounds. 
There are two main ways of converting a saturated 17 -keto 
compound into a C compound. The first is due to St. Andre et al.2 
who treated 3ß- acetoxyandrost- 5 -en -17 -one with bromine to protect 
the double bond, treated the dibrornide with chromic anhydride in 
acetic acid and then removed the bromines with zinc. The product 
contained 25% of a polar 14- hydroxy compound, which has subsequently 
been identified87 as 3ß- acetoxy- 14a- hydroxy androst- 5 -en -17 -one. 
This hydroxy compound has been reported to dehydrate with potassium 
bisulphate and acetic anhydride at 100° to give the 14,15- double 
bond.22 This method has been used on several occasions86,88 
despite the low yields of the reaction. For the synthesis of 
2N5 steroids a 65,14 diene is not desirable because selective 
reaction between these double bonds is not possible. The St. 
Andre method was an obvious possibility of getting to 3ß- acetoxy- 
5a,6ß- dichloroandrost- 14 -en -17 -one. 3R- Acetoxy- 5cu,,e4- dichloro- 
androstan-17-one was prepared by chlorinating the L\5 compound with 
sulphuryl chloride and pyridine followed by an ether extraction 
and crystallisation; but when this compound was put through the 
chromic anhydride oxidation in acetic acid no reaction was 
observed. It had been noticed in previous brominations of 5,6- 
double bonds in the presence of a 17- ketone that hydrogen bromide 
was generated, presumably due to bromination at C -16. It was 
thought possible that in the reaction sequence of St. Andre, the 
failure to isolate the dibromo compound meant that the oxidation 
reaction took place in the presence of strong acid, consequently 
the oxidation of the dichloro compound was repeated but this time 
with the addition of hydrogen bromide in acetic acid. In the 
presence of HBr the reaction observed by St. Andre et al. occurred 
and crystalline 3ß-acetoxy-5a,6p- dichloro -14a- hydroxyandrostan - 
17 -one was isolated. The yield in this reaction was lower than 
that of the previous workers and attempts to improve the yield 
by varying the concentration and nature of the acid failed. 
Performing the reaction at 100° gave lower yields. The 14a- 
hydroxy compound obtained was put through the dehydration pro- 
cedure but no crystalline product could be obtained even after 
chromatography on alumina. 
The second main preparation of 
614 compounds proceeds through 
the p15 -17- ketone. This enone was first reported by Fajkos89 
who reacted the 
616 
-17- acetate with N bromo'succinimide to give 
the 15p -bromo compound and the remaining enol acetate was treated 
with bromine to introduce a 16a-bromo group. The result was a 
trans diaxial dibromo compound which could easily be debrominated 
to give the 615 -17- ketone. This reaction has not been used to 
any extent since, although the yields reported were good. The 
first synthesis cleverly avoided the difficulty in the preparation 
of the -17-ketones, namely that the very reactive nature of 
the enone group causes intermolecular additions in the presence 
of base90 and therefore dehydrobromination of an a -bromo ketone 
is ruled out. Subsequent methods have depended on the 
-64- 
preparation of a 16a- bromo -17- ketal, dehydrobromination with 
strong base, then mild hydrolysis of the ketal.91,92 In the first 
case reported the bromo ketone was ketalised, but recently bromina- 
tion a to a ketal has been reported to occur in good yields and 
the best synthesis of the lN 15 -17- ketone follows the lines of 
Djerassi et aí.92 The v 15-17-ketone rearranges to a o14 -17- 
ketone in the presence of acid. 
90 
The reactions of the 14,15- double bond in the androstane 
series have not been widely investigated. When a 17- ketone is 
present the peroxidation of this double bond with a per.cid occurs 
from the 13-face of the molecule to give the l4ß,15ß- oxide.86 
Moreover in a similar 
014 
-17 -keto oestrane the hydrogenation of 
the 4 has been shown to produce the 14 -iso compound90 as 
a result of addition of hydrogen again from the p face of the 
molecule. However, the reaction of diborane on the 014 -17G- 
hydroxy compound has been reported to give the 15a hydroxy group8 
In a recent paper93 a synthetic oestrane type compound was 
hydrated with diborane to give the 14 -iso- l5ß -hydroxy compound. 
The use of a 143,15p oxide to obtain a 15- hydroxy steroid 
with a 17- ketone appeared to be a very difficult route. The 
best way to protect the ketone would be as the ethylene ketal 
but this group would possibly not resist the acid conditions 
necessary for the rearrangement of the oxide to a 15- ketone. A 
15,17 -diketone would be of no use for no selective reaction would 
then be available for the differentiation of these two groups. 
Moreoever, it has been reported that a 143,15ß -oxide rearranges 
0 F-1 0 0 t-' 0 0 
OH OH 
O OH 
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to a 15- keto- 14a- cardanolide94 but it has also been reported (in 
a patent)95 that a 14a,15a -oxide in the pregnane series undergoes 
rearrangement to the 14a- pre^r_^ne .., as well. Because of the 
uncertainty of the oxide route the hydration of a 14- double bond 
with diborane was considered the most hopeful route and suitably 
protected /114 steroids were prepared via the A 15 -17-ketone. 
3ß- Acetoxyandrost- 5 -en -17 -one was ketalised using an 
adaptation of the method of Delepine;97 the ketal (56) was pre- 
pared on the 100 g. scale in 93ó yield using ethyleneglycol, 
triethylorthoformate and a £- toluene sulphonic acid catalyst. 
In this ketalisation the purpose of triethylorthoformate is 
effectively to remove water, water reacts with the triethylortho- 
formate to give ethyl formate and ethanol, these both have boiling 
points below 900 and can be distilled from the reaction mixture 
(all other reactants have boiling points above 1200). The water 
which is removed is that formed in the equilibrium between 
ethyleneglycol and steroid ketone and this removal of one of the 
products of the equilibrium ensures very efficient ketalisation. 
The removal of the ethanol and ethylformate are not essential if 
lower yields are to be accepted, and the reaction has been 
carried out at room temperature when the reaction time was 
extended to 48 hours. 
The ketal (5ó) was brominated in tetrahydrofuran with either 
pyridiniumhydrobromide perbromide or trimethylammonium bromide 
perbromide.98 Bromination occurred at 5,b during this reaction 
but these bromines were subsequently removed by the addition of 
solid sodium iodide to the tetrahydrofuran solution followed by 
the addition of aqueous sodium thiosulphate. The overall yield 
for the bromination of the ketal was 74%. The dehydrobromina- 
tion of the ketal was best achieved in dimethylsulphoxide99 and 
to make the ketal more soluble in this solvent the 30- acetate 
was hydrolysed.. The resulting 16a-bromo-17- ethylenedioxy -30- 
hydroxyandrost -5 -ene (58) was treated with resublimed potassium 
tertiary -butoxide in dry dimethylsulphoxide at 40° for twelve 
hours, the steroid was then recovered with an ether extraction. 
This method usually gave very good yields. The X15 -17 -ketal 
could be readily hydrolysed to the enone (60) by reaction with 
£- toluenesulphonic acid in aqueous acetone at room temperature. 
The t15 -17- ketone (60) may be rearranged to the 1 4- isomer 
by re iuxing with acid in toluene, but to avoid formation of a 
5,14 -diene with no possibility of a selective reaction, the 5,6- 
double bond was first protected. The 30 hydroxy- eneone (60) 
was acetylated and the resulting acetate (61) was reacted with 
sulphuryl chloride and pyridine to give 3(3- acetoxy- 5a,6ß -dichloro- 
androst- l5 -en -17 -one (59). This enone was isomerised to the 
14 Q -l7- ketone (b3) with p- toluenesulphonic acid in refluxing 
toluene. 
The I7- ethylene ketal of the A 14 compound could be prepared 
by using the ketalisation procedure described above with toluene 
as co- solvent to allow easier handling of the small amount of 
material; the reaction was continued until the slowly distilled 
vapour was at the temperature of boiling toluene. A further 
7 - 
protected .L 14 compound was prepared by reducing and hydrolysing 
the 14 -17- ketone (63) to give 5a,6B- dichloro -313,l7ß- dihydroxy- 
androst- 14 -ene (64). 
The hydration with diborane was tried on 5t.,6ß- dichloro -313, 
1713- dihydroxyandrost- 14 -ene (64). The 
in situ and the method of Sondheimer et 
diborane was generated 
al88 was followed closely 
except that sodium borohydride was substituted for lithium 
aluminium hydride as the generating agent, this was done to protect 
the chlorines which might have been reduced by the latter reagent. 
The result of the hydration sequence was a mixture of products; 
thin layer chromatographic analysis showed five spots, these were 
bronze in colour indicating that the 5,6- dichloro grouping had 
remained intact and this was subsequently confirmed by n.m.r. 
spectroscopy. The polarities of the spots ranged from that of 
the original diol to considerably more polar material which might 
correspond to a 15a- hydroxy triol. The crude hydration mixture 
was chromatographed on alumina and the component corresponding to 
the most polar spot on t.l.c. was isolated. This material was 
dechlorinated with zinc and acetic acid to give a 3ß hydroxy-o5 
substance, which was evident from a n.m.r. spectrum in pyridine 
and the fact that it stained bright pink with antimony trichioride 
in chloroform. The material was semi -crystalline and could be 
recrystallised from methanol - benzene to give material with a 
melting point range 240 -2500. This material was apparently 
homogeneous on t.l.c. and g.l.c., however when the trimethylsilyl 
ether derivative was prepared, this chromatographed on g.l.c. to 
give two equal area peaks of retention times 1.70 and 2.38 (relative 
41 
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to 3f- hydroxyandrost- 5 -en -17 -one). The mixture of ethers was 
further analysed by combined g.l.c. and mass spectrometry; the 
ethers were both tris(trimethylsilyl)ethers and the mass spectra 
of the two compounds were both indistinguishable from the mass 
spectrum. of 3(3,15,17p- tris(trimethylsilyloxy)- androst- 5 -ene. 
The preparation of the 3f,15p,17p triol is described later. 
These results indicate that the diborane addition has not 
been selectively from the a face of the molecule, this may be 
partly due to the chlorines at 5 and 6. The preparation of the 
two triols of similar polarity, which appear to be 3,15,17'- 
triols, can be explained if it is assumed that the attack of di- 
borane is from both sides of the molecule. Since diborane would 
be expected to give a cis addition product, the two triols would 
be 3G, 15a,173- trihydroxyandrost -5 -ene (68) and 3,15 ,17p -tri- 
hydroxy- l47- androst-5-ene (69). Although the 15a- and 15f- 
hyd-roxy groups confer different polarities on the molecules of 
the 14a- androstane series and are easily separable by column chroma- 
92 
tography, this does not hold if there is a change in configuration 
at C -14. It is therefore not unreasonable that these two triols 
should have very similar polarities, but in the gas liquid 
chromatography of tris(trimethylsily4 ethers it is the molecular 
shape which is the main factor in the separation and in this 
respect the two derivatives are decidedly different. 
A further attempt at the hydroboration of a 
14 compound was 
made on 3- acetoxy- 5a, bp- dichloro- l7- ethylenedioxyandrost- l4 -ene 
(66), here the 17- ethyleneketal presents a difficulty. The 
-69- 
ketal group and the acetate group are reported to be reduced by 
lithium aluminium hydride in the presence of a Lewis acid such 
as boron trif luoride.88 In the diborane reaction used here the 
conditions were milder (borohydride was used) but when the ketal 
(66) was reacted with diborane generated internally, the product 
isolated was 5a,60-dichloro-3R- hydroxy- 17- (2- hydroxyethoxy)- androst- 
14 -ene (67), the structure of which was proved by n.m.r. spectro- 
scopy and the fact that it could not be hydrolysed by aqueous 
acidic acetone. Attempts at reaction of the 17- ethylenedioxy -d 4 
compound (66) with diborane generated externally failed to produce 
any reaction even though long reaction times were used. 
Reactions of the 015 -17 ketones have been the most convenient 
source of 15 substituted steroids, one of the advantages of this 
route is that it need not involve a ketone at the 15 position and 
the consequent uncertainty of the configuration at the 14 position. 
The generalisation of normal attack from the a -face of the 
steroid molecule does not hold in the D -ring. It has already been 
mentioned that attack on the 14,15- double bond has been reported 
to occur from different faces of the molecule depending on the 
86,88,90,93 In the case of the d 5 -17 ketone substituent at C -17. 
attack has consistently been from the p-face. Firstly the X15-17 - 
ketone has been peroxidised with alkaline peroxide to give a l5ß, 
l6ß -oxido ketone92 and secondly both methanol and benzyl alcohol 
add 1,4 across the enone to give ß substituents100 These reactions 
have meant that 15ß substituents have been much easier to prepare. 
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keto compound was to add benzyl alcohol across the enone and to 
hydrogenolyse the 15ß- benzyloxy group to a hydroxyl. This hydroxy 
ketone may subsequently be reduced to a 15R,17ß- dio112 These 
preparations have been carried out in the oestrane and andros- 
tane101 series, but no 15 substituted steroids in the androst -5- 
ene series have been reported. The interest in the oestranes 
has been mainly because of the isolation of 153 - hydroxyoestrone 
and 15R hydroxy- 173- oestradio112 A recent paper reported the 
synthesis of a 15ß,17ß -diol of the androstane series by the lithium 
aluminium hydride reduction of 15R ,163- oxidoandrostan- 17- one.101 
Djerassi92 has used this oxido ketone derivative for the synthesis 
of 15- monosubstituted androstanes. 
The preparation of the enone (60) has already been described 
and this enone has been used in the syntheses of 15 substituted 
androst -5 -enes. Benzyl alcohol was added across the enone and 
the product was acetylated to facilitate its isolation. The 
addition product was as expected a l5ß compound (70); this was 
evident from its molecular rotation, n.m.r. spectrum and polarity. 
Attempts to hydrogenolyse this 15ß benzyloxy group resulted in 
partial loss of the 5,6- double bond although a previous successful 
hydrogenolysis of a 16a benzyloxy group in the presence of a 5,6- 
double bond47 has already been mentioned. Of the remaining 
reagents which would cleave the benzyloxy group only metal in 
ammonia (or sodium in alcohol) would be suitable; reagents of 
an acidic nature which have been reported to cleave an ether group 
(hydriodic acid102and boron$trifluoride in acetic anhydride ) 
-71- 
would not be suitable because both the resulting 15ß hydroxy and 
the original 15ß benzyloxy groups are unstable to acid. Un- 
fortunately, the reagents which are suitable az regards the 5,6- 
double bond and the 15 substituent will reduce the 17- ketone, 
consequently for the preparation of the 3p,15ß,170- triol (74) the 
diol (71) was first prepared by reduction of the benzyloxy ketone 
with lithium aluminium hydride. The diol (71) reacted smoothly 
with calcium in liquid ammonia to give the required triol. The 
l5ß hydroxy -l7- ketone could therefore be prepared if it was 
;possible to obtain the 15p- enzylpxy- 17- ethyleneketal (72) in 
reasonable yield. It was found however that this ketal could not 
be prepared by conventional ketalisation reactions since the acid 
catalyst caused the elimination of benzyl alcohol from the 
system at the high temper4tures normally used. The conventional 
ketalisation was carried out on 3p- acetoxy -15p benzyloxyandrost- 
5-en-17-one (70) and the sole product of the reaction was 3ß- 
acetoxy-17- ethylenedioxyandrosta -5,14 -diene (73). It seemed 
probable that the elimination of benzyl alcohol was due to the 
relatively high temperature of the ketalisation reaction and 
consequently the modification of the ketalisation reaction already 
described was carried out at room temperature on the l5R= benzyloxy- 
17- ketone (70). The result of this ketalisation was a low yield 
of the required ketal (72) which was identified by infrared and 
n.m.r. spectroscopy. As well as the required ketal considerable 
amounts of diene and unreacted starting material were obtained. 
It has been shown101that a 15ß,l6ß -oxido -17- ketone is reduced 
-72- 
with lithium aluminium hydride to a 150,17ß -diol and it is 
therefore possible that a 15ß,16ß -oxido- 17- ethyleneketal would 
be reduced to a 15R hydroxy -17 ketal which would be a useful 
intermediate for the synthesis of the required steroids. It was 
thought that the 15,16 -bond in the 2N, 
15 
unsaturated ketal (62) 
might be easily peroxidised and consequently selectively peroxi- 
dised in the presence of a 215 double bond. However, an attempted 
peroxidation followed by an acetylation gave a mixture which was 
chromato graphed on alumina to give 313- acetoxy -17- ethylenedioxy- 
5a,6a-oxidoandrost 15 -ene which was identified by its n.m.r. 
spectrum. This spectrum showed the characteristic quartet and 
doublet of the 15 and 16 protons as well as only one oxide proton. 
The a- configuration of the oxide is deduced from the 6BH,7ßH 
coupling constant of 4.5 c.p.s., which is in the characteristic 
104 
range for the a oxide. If the oxide had been 5ß16p the coupling 
constants 6aH,74H and 6aH,7ßH would have been in the ranges 0 -0.6 "Y 
and 1.9 - 2.6irespectively. 
It has not been possible to synthesise 3ß- acetoxy- 5a,6G- 
dichloro-l7- ethylenedioxyandrost- 15 -ene because there has been no 
chance of selectively forming the dichloro compound. It is 
unlikely that a 5a,6ß- dichlorocompound will withstand the dehydro- 
bromination conditions necessary to form the 415 bond and if the 
chlorines were not introduced at this stage in the sequence it 
would lead to a system of two olefinic bonds. Unfortunately 
when the enone is formed, although it now becomes possible to 
selectively chlorinate the 5,6- double bond in the manner already 
-73- 
described to give (59) it is not possible to reintroduce the 
ketal group because the necessary acid catalysis would probably 
rearrange the 
X15 
bond to 4,14. 
No efficient synthesis of 15 hydroxy -17- ketones in the 
androst -5 -ene series has b een found and it is thought probable 
that the best method would be the microbiological introduction 
of a 15a substituent on a 3 -keto- Q4 compound and the subsequent 
introduction of the A5 bond by the deconjugation and reduction 
route already described. 
EXPERIMENTAL SECTION 
For general Experimental Procedure see page 32 
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3P- Acetoxy- 50,6,(3- dichloroandrostan -17- one. - 3R-Acetoxyandrost-5-en- 
17 -one (9 g.) was dissolved in benzene (280 ml.) and pyridine (15 ml.), 
the solution was stirred at 0° while a solution of redistilled 
sulphuryl chloride (4.09 g., 1.1 eq.) in benzene (40 ml.) was added 
over a period of ten minutes. The solution was stirred for twenty 
minutes after the addition of the sulphuryl chloride, then water 
was added and the steroid was extracted into ether. The ethereal 
solution was washed with sodium carbonate solution and evaporated to 
dryness. The residue was recrystallised from methanol to give 3f- 
acetoxy- 5a,6ß- dichloroandrostan -l7 -one, (7.2. g.), m.p. 220 -222 °, 
(lit25 m.p. 217- 218 °). 
The oxidation of 3ß -a cetoxy- 5a,6P- dichloroandrostan -l7 -one with 
chromic anhydride in acetic acid catalysed with hydrobromic acid. - 
3h- Acetoxy- 5a,63- dichloroandrostan -l7 -one (8.1 g.) was dissolved 
in benzene (60 m1.) and acetic acid (60 ml.). Chromic anhydride 
(40 g.) was pulverised and added to acetic acid (200 ml.) and 
commercial 60' HBr in glacial acetic acid (20 ml.); the mixture 
was cooled to 200. The solution of steroid was then added and 
the mixture was stirred at 200 for thirty minutes. The mixture 
was poured into an aqueous solution of sodium bisulphite and the 
steroid was extracted with three 300 ml. portions of chloroform; 
the chloroform solutions were combined and washed three times with 
10ÿ,T aqueous potassium hydroxide then with water and with saturated 
salt solution. The chloroform solution was dried with magnesium 
sulphate and evaporated to dryness. The residue (7.6 g.) was 
chromatographed on alumina (20 g.). Elution with benzene -ether 
(50:50) gave crystalline material which was recrystallised 
from 
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methanol to give starting material (4.6 g.); elution with ether - 
chloroform (7:3) gave non -crystalline material (0.27 g.); elution 
with chloroform gave crystalline material which was recrystallised 
from methanol to give 3f3-acetoxy-5a,6p- dichloro- 14a- hÿdroxyandrostan- 
17 -one (0.70 g.) m.p. 208 -2100; [alp -19° (c 0.1); /,1 max.(CfBr3) 
3580, 1730, 1250, 1034 and 902 cm.l; n.m.r. c8.96 (C -18 methyl), 
8.58 (C -19 methyl), 7.97 (acetate methyl), - 5.55 multiplet (6H). 
(Found: C, 59.8; H, 7.3. 021H3004012 requires C, 60.4; H, 7.2%). 
This oxidation was carried out with the omission of the hydro - 
bromic acid catalyst and t.l.c. analysis of the isolated product 
showed there to be no significant component other than the starting 
material. Substitution of borontrifluoride etherate (10 ml.) for 
the hydrobromic acid produced no 14a- hydroxy compound. When the 
reaction was performed using concentrated sulphuric acid (1 ml.) and 
70% perchloric acid (0.5 ml.) as catalysts, a small amount of 14a- 
hydroxy steroid was obtained but never in more than 5% yield. when 
these two acids were used the total weight of recovered material was 
less than 4 g. The acidic material from this reaction which was 
recovered in the alkaline wash was not investigated further. The 
reaction was also performed at 100° using hydrobromic acid as the 
catalyst, the yield in this case was 10;- of the 14a- hydroxy steroid. 
Attempted dehydration of 3ß-Acetoxy-5a,53- dichloro -l4a- hydroxy- 
androst -l7 -one.- 3(3-Acetoxy-5a,6ß- dichloro- l4a.- hydroxyandrost -l7- 
one (500 mg.) .was dissolved in acetic anhydride (5 in1.) and fused 
potassium hydrogen sulphate (500 mg.) was added; the solution was 
heated at 100° for fifteen minutes. The solution was cooled and 
poured into water, the steroid was recovered with an ether extrac- 
tion, the product was a gum which was chromatographed on alumina 
(b 
(50 g.). No crystalline product could be isolated from the mixture. 
33- Acetoxy- 17- ethylenedioxyandrost -5 -ene (56).- p- Toluenesulphonic 
acid (2 g.), 3P- acetoxyandrost- 5 -en -17 -one (1) (105 g., 0.32 mole), 
ethyleneglycol (60 ml., 1 mole) and triethylorthoformate (150 ml., 
1 mole) were stirred together at 90° in an apparatus fitted with 
a reflux condenser and provision for the exclusion of moisture. 
After one hour the solvent was gradually distilled off and the 
distillation was continued until the temperature of the reaction 
mixture reached 110 °, at this stage all the ethanol and ethyl 
formate had been removed. The hot reaction mixture was poured 
with caution into hot methanol (1.2 1.) containing pyridine (15 ml.), 
water (300 nil.) was then added and the solution was .allowed to cool 
slowly to room temperature. The crystals which formed were 
filtered off and dried to give 3p- acetoxy- l7- ethylenedioxyandrost- 
5 -ene (110 g.) m.p. 143 -144 °. (Lit.133m.p. 140- 142 °). 
Room temperature ketalisation of 3p-acetoxyandrost-5-en-17-one.- 
y -Toluenesulphonic acid (2 g.) was dissolved in triethylorthoformate 
(260 ml.) and solvent (20 ml.) was distilled off; the solution was 
allowed to cool and then 3p- acetoxyandrost- 5 -en -17 -one (80 g.) and 
ethyleneglycol (40 ml.) were added. The mixture was stirred at 20° 
for 48 hours, after 4 hours the reaction mixture was homogeneous. 
When the reaction was over, solvent (250 ml.) was evaporated off at 
300 on a rotary evaporator. The solution which was largely free of 
benzene was poured into methanol (500 ml.) and the steroid precipita- 
ted out of solution. The precipitated material was filtered off and 
recrystallised from aqueous methanol to give 3p- acetoxy- l7- ethylene- 
133 , 
dioxyandrost-5-ene, (60 g.), m.;. 143-144 
° 
(lit., m.p. 140-142°). 
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3ß- Acetoxy -16a- bromo -17- ethylenedioxyandrost -5 -ene (57) 
3ß- Acetoxy- 17- ethylenedioxyandrest -5 -ene (56) (50 g.) was 
dissolved in freshly distilled anhydrous tetrahydrofuran (150 
ml.), pyridinium hydrobromide perbromide (100 g.) in tetrahydro- 
furan (150 ml.) was added and the resulting mixture was stirred 
for two hours, after which time pyridinium hydrobromide had 
precipitated and the remaining solution was pale orange. Sodium 
iodide (75 g.) was finely ground and added to the reaction mixture 
which was stirred for half an hour; during this time the solution 
became dark brown with liberated iodine. A solution of sodium 
thiosulphate (100 g.) in water (150 ml.) and pyridine (30 ml.) 
was added and the solution was stirred for two hours. The reac- 
tion mixture was diluted with water (300 ml.) and the tetrahydro- 
furan was evaporated under vacuum. The crystalline material which 
formed was filtered off, washed well with water, dried and then 
recrystallised from aqueous ethanol to give 3R- acetoxy -16a- bromo- 
17- ethylenedioxyandrost -5 -ene (57) (45 g.) m.p. 189 -191 °. Con- 
centration of the mother liquors from the crystallisation gave a 
second crop (5 g.) m.p. 185 -189° which was sufficiently pure for 
the next stage of the reaction. An analytical sample was 
recrystallised again from methanol m.p. 190 -192e; [a]D -101° (c 
0.1) p max 1740, 1363 and 1240 cm. -1 (Found: C, 61.0; H, 7.5; 
Br, 17.4. C23H3304Br requires C, 60.7; H, 7.3; Br 17.6 %). 
16a- Bromo -3ß hydroxy -l7- ethylenedioxyandrost -5-ene (58) 
3ß- Acetoxy -16a bromo-l7- ethylenedioxyandrost -5 -ene (57) (50 g.) 
was dissolved in hot benzene (200 ml.) and hot methanol (2 1.) was 
-78- 
added, the solution was ref luxed and a solution of potassium 
hydroxide (40 g.) in water (300 ml.) was added. The solution was 
refluxed for three hours then 200 ml. of solvent was distilled off 
and the reaction mixture was allowed to cool slowly to room 
temperature. The crystals which formed were filtered off, washed 
with methanol and dried. The product was recrystallised from 
aqueous methanol to give 16a- bromo -3ß hydroxy -l7- ethylenedioxyandrost - 
5 -ene (58) (40 g.) m.p. 179 -181 °. [air, -91° (c 0.1); j,) 3600, 
1388, 1217, 1110 and 1040 cm71 n.m.r.2:9.10 (C -18 methyl), 19.00 
(C -19 methyl), ÿ 5.3 to 6.2, multiplet (four ethylene ketal protons) 
and 4.66, multiplet (6H). An analytical sample was recrystallised 
from acetone, m.p. 179 -181 °. (Found: C, 61.6; H, 7.4; Br, 19.2. 
C21H3103Br requires C, 61.2; H, 7.6; Br, l9.4¡ó). 
17- Ethylenedioxy -3ß hydroxyandrosta- 5,15 -diene (62) 
16a -Bromo -17- ethylenedioxy -3ß hydroxy androst -5 -ene (58) (9.5 
g.) was dissolved in dry dimethylsulphoxide (120 ml.) at 40 °. 
Resublimed and freshly dried potassium tert. - butoxide (5.5 g.) was 
added to the steroid solution under nitrogen. The reaction flask 
was stoppered and left to stand at 40° for twelve hours. The 
solution was then poured into dry ether (1 1.) and the ether was 
shaken until any precipitated solid had been dissolved. Water 
was added and the ethereal solution was washed with wE vr followed 
by saturated salt solution. The solution was dried with magnesium 
sulphate and evaporated to dryness. The crystalline residue was 
recrystallised from aqueous ethanol to give 17-ethylenedicxy-3ß- 
hydroxyandrosta- 5,15 -diene (7.2 g.) m.p. 150 -156 °; [a]D -176° 
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(c 0.1); V max 1381, 1348, 1200, 1110, and 1050 cm 71; n.m.r. 
T 9.07 (C -18 methyl), T8.96 (C -19 methyl), '`Z 6.07 (four ethylene 
ketal protons), T4.63 multiplet (6H), ` :4.30 quartet (15H) and 
'13.87 doublet (16H). An analytical sample was recrystallised 
from acetone- hexane. M.p. 158 -161 °. (Found: C, 76.7; H, 9.2. 
C21H3003 requires C, 76.3; H, 9.15 %). 
3R- Hydroxyandrosta- 5,15 -dien -l7 -one (60) 
l7- Ethylenedioxy -3ß hydroxyandrosta- 5,15 -dien -l7 -one (62) (10 
g.) was dissolved in absolute acetone (500 ml.), a solution of 2.- 
toluenesulphonic acid (500 mg.) in water (50 ml.) was added and the 
solution was kept at 15° for 16 hours. Water (150 ml.) was added 
to the solution, then the solution was evaporated to half its 
volume at 25 °. Material which crystallised during evaporation 
was filtered off, washed well with water and dried in vacuo to give 
3R hydroxyandrosta- 5,15 -dien- 17-one (8 g.) m.p. 185 -190 °. An 
analytical sample was recrystallised from ethyl acetate, m.p. 202- 
205°; [a]D -150° (c 0.1); A max 231 5, (c =7,700) (ethanol); 
-1 
Y max 3600, 1708, 1048 and 823 cm. ; n.m.r. 
,1 8.91 (C -18 and C -19 
methyls), X4.55 multiplet (6H), T3.94 quartet, J15,16 =6 c.p.s., 
J14,1 5=2.8 c.p.s. (15H), T 2.48 doublet J15,16 =6 
c.p.s. (16H); 
(Found: C, 79.3; H, 9.2. C19H2602 requires C, 79.7; H, 9.15%). 
3ß- Acetoxyandrosta -5,15 -dien -17 -one (61) 
3ß- Hydroxyandrosta -5,15- dien -17 -one (60) (8.0 g.) m.p. 185- 
190°) was dissolved in pyridine (50 ml.) and acetic anhydride (100 
ml.). The solution was kept at 20° for three hours then poured 
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into stirred crushed ice. The mixture was allowed to warm up 
to room temperature, the crystals which had formed were filtered 
off, washed well with water and dried in vacuo at 100° to give 
3ß- acetoxyandrosta -5,15 -dien -l7 -one m.p. 185 -190 °. An analytical 
sample was recrystallised from acetone hexane, m.p. 193 -1960; 
[a]D -138° (c 0.1); 7/ max 1730, 1710, 1245, 1037 and 827 cm:1; 
(Found: C, 76.5; H, 8.5. C21H2803 requires C, 76.8; H, 8.6 %). 
3ß- Acetoxy- 5a, 6ß- dichloroandrost- l5- en- 17-one (59) 
A solution of 3ß- acetoxy androsta -5,15- dien -17 -one (61) (8.5 
g. m.p. 185 -190 °) in benzene (150 ml.) and pyridine (15 ml.) was 
cooled to 00, solid benzene began to separate out and subsequent 
additions were carried out in the presence of solid benzene. 
Sulphuryl chloride (3.95 g., 1.12 mole) in dry benzene (72 ml.) 
was added slowly, keeping the temperature of the reaction below 2 °. 
When the addition was complete the flask was allowed to warm to 
15° and the steroid was extracted into ether. The ethereal solu- 
tion was washed with water, sodium carbonate solution and saturated 
salt solution, dried with magnesium sulphate and evaporated to 
dryness. The residue was recrystallised from aqueous acetone to 
give 3ß- acetoxy- 5a,6ß- dichloroandrost- l5 -en -17 -one (5.6 g.)'m.p. 
189 -191 °. An analytical sample was recrystallized from acetone, 
m.p. 189 -191 °; [a]D -110° (c 0.1); X max 231 miA (& -8840) 
(ethanol) 
1728, 1709, 1244, 1021, 826 and 658 cm. -1 (Found: C, 63.4; 
H, 7.1; Cl, 17.6. C21H2803C12 requires C, 63.0; H, 7.1; Cl, 
17.7%). 
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3p- Acetoxy -5a,6ß -dichloroandrost- l4 -en -17 -one (63) 
3p- Acetoxy- 5a,6ß -dichloroandrost- l5 -en -17 -one (59) (2.1 g.) 
was dissolved in dry toluene (250 ml.) and k- toluenesulphonic acid 
(200 mg.) was added. The mixture was ref luxed for two hours. 
The solution was then cooled and diluted with ether (500 ml.), 
washed with sodium carbonate solution and saturated salt solution 
and dried with magnesium sulphate. Evaporation gave a product 
which was recrystallised from aqueous methanol to give 3p- acetoxy- 
5a,6ß- dichloroandrost- 14 -en -17 -one (1.3 g.) m.p. 178 -180 °. An 
analytical sample was recrystallised from methanol, m.p. 178 -1790; 
[a]El +25° (c 0.1); Y max 1737, 1244, 1044 and 664 cm71; n.m.r. 
1-8.86 (C -18 methyl), 8.59 (C -19 methyl), 7.97 (acetate methyl), 
15.62 multiplet (6H), 4.46 multiplet (15H). (Found: C, 63.2; 
H, 7.4; Cl, 17.5. C21H2803C12 requires C, 63.0; H, 7.1; Cl, 
17.7%). 
3p- Acetoxy- 5a, 6p- dichloro- l7- ethylenedioxyandrost- 14 -ene (66) 
3p- Acetoxy -5x,60- dichloroandrost- 14 -en -17 -one (63) (330 mg.) 
was dissolved in dry toluene (15 ml.) and ethylene glycol (2 ml.), 
triethylorthoformate (4 m1.) and £- toluenesulphonic acid (40 mg.) 
were added. The solution was stirred and heated under ref lux 
with an air condenser. The heating of the flask was adjusted 
so that the condensing vapours almost reached the top of the air 
condenser, this arrangement ensured that little toluene or 
triethylorthoformate was lost from the solution whilst any ethanol 
or ethyl formate formed during the reaction was removed from the 
system. After two hours of refluxing the flask was cooled and 
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pyridine (0.5 ml.) was added. The steroid was isolated by ether 
extraction. The reaction product was recrystallised from aqueous 
methanol to give 3p- acetoxy- 5a,6p- dichloro- l7- ethylenedioxyandrost- 
14 -ene (106 mg.) m.p. 159- 162 °. An analytical sample was re- 
crystallised from aqueous methanol. M.p. 162 -163°; [alp -119° 
(c 0.1) 
) max 1734, 1245, 1035 and 655 cm71; n.m.r. X8.92 (C -18 
methyl), r- 8.62 (C -19 methyl), 7.98 (acetate methyl), -t 6.09 
(four ethylene ketal protons), 'Z 5.57 multiplet (6H) and 4.78 
multiplet (15H). (Found: C, 62.2; H, 7.4; Cl, 16.3. 023H3204C12 
requires C, 62.2; H, 7.3; Cl, 16.0 %). 
5a,6ß- Dichloro- 3ß,17ß- dihydroxy androst- 14 -ene (64) 
3ß- Acetoxy- 5a,6ß -dichloroandrost- l4 -en -17 -one (63) (2.8 g.) 
was stirred with sodium borohydride (500 mg.) in 90% aqueous methanol 
(200 ml.) for 16 hours. Water was then added followed by dilute 
hydrochloric acid, the steroid was extracted into chloroform. The 
chloroform solution was washed with sodium carbonate solution and 
saturated salt solution, dried with magnesium sulphate and evaporated 
to dryness. The residue was recrystallised from benzene to give 
5a,6ß -dichloro- 3ß,17p- dihydroxyandrost- 14 -ene (2.1 g.), m.p. 160- 
168°. An analytical sample was purified by alumina chromatography 
and recrystallised from hexane. M.p. 166 -169 °; [alp -38° (c 0.1); 
P max (CHC13) 1068, 960 and 908 cm.-1; n.m.r. (pyridine) 
T. 8.76 
(C -18 methyl), 'Z 8.59 (C -19 methyl), 5.40 multiplet (16H) and 
4.86 multiplet (15H). (Found: C, 66.5; H, 9.0. C19H2802C12: 
C6H14 requires C, 66.0; H, 9.2%). 
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The Reaction of Diborane on 5a,616 Dichloro-3ß- l7ß- dihydroxyandrost- 
14 -ene.- 5a,6ß- Dichloro -3ß,17ß -dihydroxyandrost- 14 -ene (64) (500 
mg.) and sodium borohydride (2 g.) were dissolved in dry dioxan 
(10 ml.) and the solution was cooled to 10 °. A solution of 
redistilled borontriluoride etherate (3 ml.) in dioxan (10 ml.) 
was 4dded dropwise over forty minutes with continuous stirring 
and cooling. The mixture was stirred for a further twelve hours 
at 18 °. The reaction mixture was then poured into a solution of 
potassium hydroxide (1 g.) in water (10 ml.) and methanol (90 ml.) 
this mixture was stirred and cooled with ice for ten minutes. 
The stirring and cooling were continued while 30; hydrogen peroxide 
(30 ml.) was added slowly over twenty minutes. The mixture was 
stirred for a further ten minutes at room temperature. Water and 
chloroform were added and the chloroform solution was washed 
successively with water, ferrous sulphate solution, dilute hydro- 
chloric acid, sodium carbonate solution and saturated salt solution. 
The solution was dried with magnesium sulphate and evaporated to 
dryness. The residue was analysed by thin layer chromatography 
using 10; ethanol in benzene as the solvent system (system K)19 
development of the plate with antimony trichloride in chloroform 
showed five bronze coloured spots which had Rm values 0.92, 0.86, 
0.69, 0.63 and 0.54. The least polar spot had a polarity identical 
to that of 5a,6ß- dichloro- 3ß,17ß -dihydroxyandrost- l4 -ene. The 
total reaction product was chromatographed on alumina (100 g.), 
elution with methanol- chloroform (1:9) gave non -crystalline 
material (140 mg.) which showed one spot on thin layer chromato- 
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acetic acid (30 ml.) and zinc dust (500 mg.) was added, the mixture 
was stirred at 100° for one hour. The reaction mixture was 
filtered and water was added to the filtrate, the s5eroid was 
extracted with chloroform. The residue from this extraction 
showed one major bright pink spot on thin layer chromatography, 
RD 0.42. This crude material was semicrystalline and crystals 
could be obtained by recrystallisation from methanol -benzene; 
m.p. 240 -2500. Gas chromatographic analysis of this crystalline 
material showed only one peak of relative retention time 1.82. 
The tris(trimethylsily 4) ether of this material was prepared using 
hexamethyldisilazane and trimethylchlorosilane in pyridine. Gas 
chromatographic analysis of this tri -ether showed two peaks of 
equal area (electronic integrator) and of relative retention times 
1.70 and 2.38. The mass spectra of these two components were the 
same and both spectra were indistinguishable from the mass spectrum 
of pure 3ß,15R,17ß- trihydroxy androst -5 -ene tri4rimethylsily1,) ether. 
The n.m.r. (pyridine) spectrum of the mixed triols (68,69) had 
peaks at '8.94, 8.90, 8.87 and 8.73. (Two C -18 methyl groups 
and two C -19 methyl groups; not assigned). 
Attempted Hydroboration of 3R- Acetoxy- 5a,6ß -dichloro- l7- ethylene- 
dioxyandrost- 14 -ene.- 3ß- Acetoxy- 5a,6ß- dichloro -17- ethylene- 
dioxyandrost- l4 -ene (66) (300 mg.) was reacted with diborane 
generated internally using the same conditions and isolation 
procedure as for the reaction of compound (64) above. The 
residue was chromatographed on alumina (30 g.), activity III. 
.elution with ether gave crystalline material (180 mg.) which was 
-85- 
recrystallised from acetone -hexane to give 3R- hydroxy- 5a,6p- 
dichloro- l7-( 2- hydroxyethoxy)- androst- 14 -ene (67) m.p. 82 -85 °; 
[a]D -50° (c 0.1); ) max 3550, 1136 and 656 cm.1; n.m.r.Z 9.00 
(C -18 methyl), t 8.65 (C -19 methyl), ' 6.38 multiplet (four ethylene 
ketal protons), C 5.58 (6H) and z 4.91 (15H). (Found: C, 61.7; 
H, 8.5. C21H3403C12 requires C, 62.0; H, 8.45 %). Further 
elution with chloroform -methanol (10:1) gave hydroxylated material 
(60 mg.) which contained no hydrolysable ethylene ketal group. 
The ethereal compounds obtained in this reaction showed no change 
when they were heated for four hours in ref luxing aqueous acetone 
containing £- toluenesulphonic acid. 
3ß- Acetoxy -15ß benzyloxyandrost- 5- en- 17-one (70) 
Androsta- 5,15 -dien- 3ß- o1- 17-one (60) (9.5 g.) was stirred as 
a slurry with benzyl alcohol (15 ml.) and powdered sodium hydroxide 
(200 mg.) under nitrogen for twelve hours. The benzyl alcohol 
solution was added to acetic anhydride (100 ml.) and pyridine (30 
ml.) and the mixture was stirred for three and a half hours at 
room temperature. The acetylation mixture was evaporated to 20 
ml. in vacuo and the residue was taken up in ether (600 ml.). 
The ethereal solution was washed with sodium carbonate solution 
and with saturated salt solution and was dried with magnesium 
sulphate and evaporated to dryness. The residue was chromato- 
graphed on alumina (300 g.); elution with petrol -benzene (9:1) 
gave benzyl acetate. Further elution with ether gave crystalline 
material which was recrystallised from methanol to give pure 
3ß- acetoxy- l5ß -benzyloxyandrost- 5 -en -17 -one (5.9 g.) m.p. 232 -233 °. 
- 86 - 
An analytical sample was recrystallised from methanol, m.p. 236- 
237°; [a]lo -47° (c 0.1); )1max.1737, 1242, 1030, 739 and 700 
cm:l; n.m.r. - 8.91 (0 -18 methyl), 8.81 (C -19 methyl), 1_7.97 
(acetate methyl) Pt 5.81 triplet (15aH), ' 5.50 doublet (benzyl 
methylene) and ! 4.61 (6H). (Found: C, 77.05; H, 8.6. 
C28H3604 requires C, 77.0; H, 8.3%). 
153- Benz.yloxy- 3ß,17ß -dihydroxyandrost -5 -ene (71) 
33- Acetoxy -l5ß benzyloxyandrost- 5- en- 17-one (70) (2.2 g.) was 
dissolved in dry tetrahydrofuran (150 ml.) and lithium aluminium 
hydride (500 mg.) was added. The solution was refluxed for one 
hour and then was allowed to cool. Excess lithium aluminium 
hydride was destroyed with ethyl acetate followed by water. 
Dilute hydrochloric acid was then added and the steroid was 
isolated using a chloroform extraction. The chloroform solution 
was dried and evaporated to dryness and the residue was recrystal- 
lised from methanol and carbontetrachloride to give l5ß- benzyloxy- 
30,17ß- dihydroxyandrost -5 -ene (1.7 g.) m.p. 180 -185 °. An analytical 
sample, crystallised from aqueous methanol had a m.p. 183 -187 °; 
[a]D -82.° (c 0.05) (Found: C, 75.4; H, 8.9. C26H3603.H20 
requires C, 75.3; H, 9.2%), 
),) 
max.(nujol) 1058, 758, 735 and 
695 cm -1 
3ß,1513,17ß- Trihydroxyandrost -5 -ene (74) 
15R- Benzyloxy- 3ß,l7ß- dihydroxyandrost -5 -ene (71) (1.5 g.) 
was dissolved in dry tetrahydrofuran (100 ml.) and this solution 
was added to a stirred solution of calcium (7.5 g.) in liquid 
-87- 
ammonia (1 litre). The mixture was stirred for twelve hours 
allowing the ammonia to evaporate. Chloroform and dilute 
hydrochloric acid were added to the residue and the chloroform 
solution was washed with water, sodium carbonate solution and 
saturated salt solution. The solution was dried with magnesium 
sulphate and evaporated to dryness. The residue was recrystal- 
lised from methanol- carbon tetrachloride to give 313,15p,17p- 
trihydroxyandrost -5 -ene (300 mg.) m.p. 244 -248 °. An analytical 
sample was recrystallised from aqueous methanol, had a m.p. 
249 -251° [a]D -72° (dioxan c 0.1), (Found: C, 70.0; H, 9.9. 
C19H3003 requires C, 70.3; H, 9.9 %), n.m.r. (pyridine) 11 8.90 
(C -18 methyl), V 8.49 (C -19 methyl), z 4.51 multiplet (6H). 
3ß- Acetoxy- 17- ethylenedioxyandrosta -5,14 -diene (73) 
3ß- Acetoxy -15ß benzyloxyandrost- 5 -en -17 -one (70) (420 mg.) 
and p- toluenesulphonic acid (20 mg.) were dissolved in toluene 
(10 ml.), triethylorthoformate (5 ml.) and ethylene glycol (2 ml.). 
The re.ction mixture was ref luxed for three hours and then cooled. 
The steroid was extracted with ether and the ethereal solution 
was washed with sodium carbonate solution and saturated salt 
solution, dried with magnesium sulphate and evaporated to dryness. 
The residue was recrystallised from methanol to give 3ß- acetoxy- 
17- ethylenedioxy androsta -5,14 -diene (250 mg.) m.p. 145 -149 °. An 
analytical sample was recrystallised from methanol, m.p. 147 -149 °, 
(Found: C, 74.3; H, 8.9. C23H3204 requires C, 74.2; H, 8.7%); 
V max.1735, 1381, 1373, 1312, 1242 and 1034 cm.1; n.m.r. 
V 8.96 
(C -19 methyl), 8.92 (C -18 methyl), 7.96 (acetate methyl), 
- 88 - 
-6.09 (four ethylene ketal protons), '1-4.78 multiplet (15H) and 
24.56 multiplet (6H). 
3ß- Acetoxy -l5ß -benzyloxy -l7 -ethylenedioxyandrost -5 -ene (72) 
3ß- Acetoxy- 15ß- benzyloxyandrost- 5- en- 17-one (70) (2.6 g.) was 
stirred with ethylene glycol (5.5 ml.), benzene (5 ml.), triethyl- 
orthoformate (15 ml.) and p- toluenesulphonic acid (0.2 g.) at 20 °. 
After fifteen hours the reaction mixture was homogeneous, the 
stirring was continued for sixty hours. The steroid was extracted 
into ether. The ethereal solution was dried and evaporated to 
dryness, the residue was chromato graphed on alumina (150 g.). 
Elution with petrol -ether (9:1) gave material (900 mg.) containing 
no benzyloxy group as shown by the absence of infrared absorption 
at 730 and 649 cm. 
-1 
Further elution with petrol -ether (6:4) gave 
3ß- acetoxy -l5- benzyloxy -l7- ethylenedioxyandrost -5 -ene (72) which 
was crystallised from methanol (350 mg.) m.p. 147 -150 °. An 
analytical sample was recrystallised from methanol, m.p. 149 -151 °; 
[a]D -100° (c 0.1); P max-1733' 1366., 1237, 1105, 
1027, 730 and 
694 cm71; n.m.r..r. 8.95 (C -18 methyl), r 8.88 (0 -19 methyl), 
t 7.98 (acetate methyl), z 6.11 (four ethylene ketal protons) and 
T5.63 doublet, J = 9 c.p.s. (benzyl methylene protons). (Found: 
C, 74.9; H, 8.5. C30H4005 requires C, 75.0; H, 8.4; (,). Further 
elution with ether gave unchanged starting material (70) (1.2 g.). 
3R- Acetoxy- l7- ethylenedioxy- 5ä,6a- oxidoandrost- l5 -ene (75) 
17- Ethylenedioxy- 3R- hydroxyandrosta- 5,15 -diene (62) (16.8 g.) 
was dissolved in benzene (600 ml.) and the solution was cooled to 
- 89 - 
10° in ice. p- Nitroperoxybenz.oic acid (18.1 g. of 55,E pera.cid 
content, = 1.06 eq.) was added over ten minutes keeping the 
temperature below 15°. The solution was stirred for 20 minutes 
at 15° and then for twelve hours at room temperature. The benzene 
solution was washed thoroughly with sodium carbonate solution 
followed by water and saturated salt solution. The solution was 
dried with magnesium sulphate and evaporated to dryness. The 
residue was dissolved in pyridine (50 ml.) and acetic anhydride 
(100 ml.) and the solution was kept at 18° for three hours. This 
solution was then evaporated to dryness in vacuo and the residue 
was chromatographed on alumina (300 g.). Elution with ether - 
chloroform (98:2) gave crystalline material (7 g.) which was re- 
crystallised from acetone- hexane to give 3ß- acetoxy- 17- ethylene- 
dioxy -5a,6a- oxidoandrost- 15 -ene (5.5 g.) m.p. 196 -199 °. An 
analytical sample was recrystallised from acetone m.p. 199 -200 °; 
[alp -156° (c 0.1); V max.1734, 1238, 1195, 1104, 1032 and 985 cm71; 
n.m.r. r 9.14 (C -18 methyl), 'r 8.90 (C -19 methyl), 8.01 (acetate 
methyl), z 7.08 doublet J6R,7R =4.5 
c.p.s. (6H), 'r 6.08 multiplet 
(four ethylene ketal protons), Z 4.29 quartet J15,16 = 6 c.p.s. 
J14,15 = 2.8 c.p.s. (15H), and 7 3.92 doublet, J15,16 = 
6 c.p.s. 
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The Synthesis of 3a 18 -Dih drox androst- 5 -en -17 -one and 3e- drox - 
18- nor- 13a- Androst- 5 -en -17 -one 
Many 18- oxygenated steroids have been derived from pregnenolone 
and conessine (3ß- dimethylaminocon- 5- enine) and since both of these 
compounds have the 5,6- double bond and a 3R substituent it is not 
surprising that 18 substituted 3R- hydroxy- A5 steroids have been 
made as intermediates in the syntheses of other steroids. Apart 
from the synthesis of the pregnenesP5,106,107pappo has reported108 
the synthesis of 30,17ß,18- trihydroxyandrost -5 -ene (80) as an inter- 
mediate in the synthesis of 18.- nor -13 androst- 4 -ene- 3,17- -dione (79). 
Early work on 18 substituted steroids was based on conessine which 
had been shown109 to contain both an 18 substituent and a A5 bond, 
the syntheses of steroids from conessine105,110 involved the inter- 
mediate 21- hydroxy -3a,5- cyclo -5a- pregn- 20- en -6-one which was 
eventually converted to a 3R- hydroxy -4N5- steroid. Most of the 
attention in the previous work however has been focussed on the 
pregnane type compounds and those with 3 -keto- 
d4 groups especially 
as intermediates in the synthesis of aldosteronelll No synthesis 
of 33,18- dihydroxyandrost- 5- en- 17-one (90) has been reported in the 
literature. 
The routes to 18 substituted steroids were examined to find 
the best preparation of a suitable intermediate. Attempts to 
introduce substituents at 0 -18 when a 17- ketone is present by the 
photolysis of a 11-nitrite have led to D -homo compounds}12 It has 
already been mentioned that the l7ß- acetyl side chain is readily 





TIIE HYPOIODITE REACTION 
(H) 
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group is also present in the molecule, however when an oxy- radical 
is generated at 20, the presence of these groups in the molecule 
present alternative breakdown paths for the radical and the result 
112 
is a completely different reaction. It was necessary therefore 
to form the usual derivative of 3p,20ß- dihydroxypregn -5 -ene [the 
hemiacetal (85)] and to use one of the side chain degradations 
105,113,114 
developed by Pappo. 
Of the methods of getting the initial 18 substituent, the 
choice was between photolysis of nitrite esters,12the hypoiodite 
reaction,15' oxidation of alcohols with lead tetraacetate117 
119 
and the homolysis of iv- chloramines118 and hypochlorites. Of 
these methods the best seemed to be the hypoiodite method which 
was originally developed by Wettstein and his coworkers, this 
reaction leads readily to an 18- hydroxy -20- ketone (hemiacetal) 
which lends itself to the side chain degradations. The method 
used was that described in the second main publication of the Swiss 
group1l6 on the hypoiodite reaction; two of the main advantages 
of this method as of the hypoiodite reaction in general are that 
no reactive intermediates have to be isolated and that no special 
light source is required. 
The hypoiodite reaction proceeds via the 20- alkoxy radical (B) 
as illustrated. The alkoxy radical is engaged in a six membered 
transition state (C) with a hydrogen from the 18- methyl group and 
this proton is exchanged to the 20- oxygen. The resulting alkyl 
radical at 18 (F) gains an iodine to give the 18- iodo- ?0- hydroxy- 











the 18- iodo -.20- hydroxy compound1but a by- product is obtained by 
further attack by the 20- hydroxy group on the 18- methylene which 
leads to an iodo -oxide or a hemiacetal both of which give the 
120 121 
lactone (G) on oxidation with Jones reagent. The iodo alcohol 
(84) was prepared and immediately oxidised to give the iodoketone 
(87) which was treated with freshly preci-ritated silver acetate 
in methanol to give the hemiketal (85). No evidence was found 
in this work of the 20- epimers of the hemiketal which were pre- 
viously reported122 T.l.c. analysis of the intermediates consis- 
tently showed single spots. The yield of the hemiacetal (85) 
from 3G- acetoxy- 20G- hydroxypregn -5 -ene was 24%. 
The method that Pappo108used to obtain 3G,17ß,18 -trihydroxy- 
androst -5 -ene (80) is not readily applicable to the synthesis of 
the 17- ketone (92), because no opportunity for selective oxidation 
exists in the method as it is reported, although since the report 
is in the form of a patent not all the details are available. 
The side chain degradation of Pappo involves the rearrangement of 
the oxime (77) which in the absence of a 17- hydroxyl group or a 
p0 bond gives the 17- acetamido compound (78). The acetamido 
group is hydrolysed to give the amine (81) which is reacted with 
nitrous acid to give the triol (80) although the yield for this 
reaction is not quoted. 
h more attractive method of removing the side chain was the 
modification of Pappo's hydroperoxide method used by Fukushima 
and Iseli 
122 
to prepare 18- hydroxyetiocholanolone. This method 
depends on the formation of the hydroperoxide of the hemiacetal 
-93- 
and this could be carried out in the presence of a 5,0- double bond 
by using 30% aqueous hydro ger peroxide. The hydroperoxide (88) was 
prepared and acetylated and this hydroperoxide acetate (89) was 
rearranged by refluxing with trimethylamine in aqueous dioxan to 
give as the main product 3P,18- diacetoxy -17p- hydroxyandrost -5 -ene 
(90) which was purified by column chromatography on alumina and 
identified by its n.m.r. spectrum. The n.m.r. spectrum showed 
one sharp peak at 1-5.75 (18- methylene) which is exactly what was 
observed by the previous workers in the etiocholane series. The 
17- hydroxy compound was oxidised to the 18- acetoxy -17- ketone (91) 
with Jones' reagent121 and this was readily hydrolysed by aqueous 
acidic methanol to give 3p,18- dihydroxyandrost- 5 -en -17 -one (92) 
in 24; overall yield from the hemiacetal (85). 
-94- 
3ß- Hydroxy -18- nor - 130 -androst- 5 -en -17 -one 
Most of the common steroid hormones have been prepared in the 
18 -nor form, however the interest in these compounds has been short 
lived because it was soon found that they did not have any 
biological activity or at least greatly reduced biological activity. 
The following syntheses are reported; 18- nor- progesterone,123 
18- nor -androst- 4 -ene- 3,17- dione108(79), 18- nor- oestrone, 18 -nor- 
testosterone1 5 and 18- nor- cortisone126 The methods of synthesis 
have been varied but for the cortisone and progesterone anologues 
the D ring has been cleaved and recyclysed and the oestrone and 
testosterone derivatives have been obtained by total synthesis. 
When Marrian first isolated 18- hydroxy- oestrone10 he found 
that when this compound was treated with base, formaldehyde was 
liberated and this liberation of formaldehyde has become almost 
a standard test for the presence of the 18- hydroxy -17- ketone group 
in a molecule. In Marrian's proof of the structure of 18- hydroxy 
oestrone the oestrogen -like material which was left after formalde- 
hyde was liberated was identified as 18 -nor oestrone by comparison 
with an authentic sample totally synthesised.124 
In the synthesis of 18 -nor androstenedione (79), 3p,1-4418- 
trihydroxyandrost-5-ene was subjected to Oppenauer oxidation and 
under the conditions of the reaction formic acid was eliminated to 
give 18- nor -13E- androst- 4 -ene- 3,17 -dione (79) as a mixture of 13- 
epimers. 
When 38,18- dihydroxyandrost- 5- en- 17-one (92) was prepared 
and this compound was chromatographed on g.l.c. one peak was 
observed of a shorter retention time than that of 3ß hydroxyandrost- 
ON 
(9 2) (93) 
THE SYNTHESIS OF 3f3-HYDROXY-18 -NOR -13a-AlvDROST-5 EN-17-ONE 
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5 -en -17 -one the shorter retention time indicated that part of the 
molecule had been lost and it was likely that formaldehyde had been 
eliminated. The sharpness of the peak indicated that the pyrolytic 
reaction had been almost instantaneous and the preparation of a 
sample of the product on a larger scale was attempted by sublima- 
tion of the 18- hydroxy -17- ketone under high vacuum. A sample of 
the 18- hydroxy compound (92) was sublimed under high vacuum to 
give a white crystalline product which could be recrystallised 
from methanol to give a crystalline material of m.p. 161 -164°. 
N.m.r. analysis of the material obtained from the vacuum 
sublimation showed the presence of only one methyl resonance at 
9.15 and no signal in the region where the 18- methylene group 
originally absorbed. Elemental analysis of the product was 
compatible with the formula 018112602 and it was clear therefore 
that an 18 -nor compound had been formed. This pyrolysis product 
behaved on thin layer chromatographic analysis exactly as material 
obtained by the treatment of the 18- hydroxy -17- ketone (92) with 
base. 
A parallel pyrolytic reaction has recently been reported by 
127 
1vlenini et al.; in this case 19- hydroxy- androstenedione eliminated 
formaldehyde on gas chromatography to give a mixture of 19 -nor 
steroids. 
It has been stated that for the junction between five and six 
membered rings the most stable configuration is cis, and for a 
compound formed under pyrolytic conditions or under basic conditions 










The Optical Rotatory Dispersion Cur-re of 
3(3- Hydroxy -l8- nor -l3a -androst- 5 -en -17 -one 
J R7?° 
The Projection of a Dreiding Model 
of 3(3- Hydroxy-18- nor -13a- androst- 5 -en -17 -one on to the 
plane which perpendicularly bisects the 
carbon -oxygen double bond 
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a ketone is present a to the ring junction. Therefore, it is 
likely that the 18 -nor compound obtained here (93) has a C /D- 
cis ring junction and this has been supported by optical rotatory 
measurements. 
The o.r.d. curves for a pair of 13- epimeric 17- ketones are 
p ublished,129 these epimers are 13p- and 13a-octanordammarane-3,17- 
dione and these exhibit positive and negative Cotton curves 
respectively although in this case the equilibrium of the two 
forms shows that the 130 is the more stable form. This however 
can be shown by the use of Dreiding models to be due to the effect 
of the 8p- methyl group which causes more non - bonded interaction 
in the 13a- epimer. The o.r.d. curve of the 18 -nor compound (93) 
is illustrated and this is a negative curve demonstrating that 
the compound here has the 13a- configuration. 
The empirical assignment of the 13a- configuration is in 
agreement with the configuration which would be predicted from 
the application of the octant rule.135 The projection of a Dreiding 
model illustrated shows that most of the steroid falls into the 
back top right octant which should confer a negative sign on the 
cotton effect curve. 
:Ë 2ERIT ENTAL SECTION 
3P- Acetoxy- 2Oß- hydroxypregn -5 -ene (83).- This compound was prepared 
by following exactly the method of Heusler, Wieland and Meystre.120 
The 2Oß- hydroxy- compound (m.p. 161 -164 °) was obtained in an 80% 
yield. 
3( 3- Acètoxy- l8- hydroxypregn- 5 -en -20 -one hemiacetal (85).- Lead 
-97- 
tetraacetate was freshly recrystallised and dried in vacuo, this 
material (15 g.) was rapidly transferred to a flask containing 
redistilled, sodium -dried cyclohexane (500 nil.) and dried calcium 
carbonate (10 g.) this mixture was refluxed for one hour. 33- 
Acetoxy- 203- hydroxypregn-5 -ene (5 g.) was then added followed by 
iodine (1.80 g.); the solution was irradiated from beneath with 
a 500 watt projector bulb, the light and heat from this bulb were 
concentrated on the flask by means of aluminium foil. The con- 
tents of the flask were stirred and the solution was boiled by 
the heat of the lamp; after twenty minutes the iodine colour had 
disappeared and the flask was cooled to room temperature. Filter- 
ing aid (Celite, 5 g.) was added and the solution was filtered, 
the filtrate was washed with aqueous sodium thiosulphate followed 
by water and dried with magnesium sulphate. Pyridine (5 ml.) was 
added to the solution and this was then evaporated to dryness in 
vacuo on a rotary evaporator at 30 -35 °. The residue was dissolved 
in acetone (100 ml.) and this solution was coaled to 2 °; 8N chromic 
acid solution121 (5.9 ml.) was added keeping the temperature below 
5° and then the solution was stirred at 2 -5° for 30 minutes. 
Sodium acetate (56 g.) in water (100 ml.) was added and the steroid 
was extracted into benzene (200 ml.); the benzene solution was 
washed with saturated sodium chloride solution, dried with magnesium 
sulphate and evaporated to dryness. The residue was dissolved in 
methanol (250 ml.) and freshly precipitated silver acetate (10 g.) 
was added, the resulting slurry was stirred and refluxed for two 
hours; the solution was cooled and filter aid (Celite) was added 
- 98 - 
The solution was filtered and the filtrate was evaporated to dry- 
ness. The residue was dissolved in ether and this solution was 
placed on a °olumn of Florisil (50 g.),elution with ether gave 
pregnenolone acetate (1.3 g.); further elation with chloroform 
gave 3R- acetoxy- 18- hydroxypregn- 5 -en -20 -one hemiacetal (85) (1.2 
g.) m.p. 171 -174 °, (lit4 m.p. 158 -161 °) [a]l) +6° (c 0.1). 
31,18- Diacetoxy- 1 7_hydroxyandrost -5 -ene (90).- 3R- Acetoxy -18- 
hydroxyandrost- 5 -en -20 -one hemiacetal (4.6 g.) and p- toluene- 
sulphonic acid (40 mg.) were dissolved in ether (10 ml.) and dioxan 
(20 ml.) and the solution was cooled to 2° in ice. 30 Hydrogen 
peroxide (4 ml.) was added over a period of 10 minutes keeping the 
temperature below 10 °; the solution was then stirred for one hour 
at 2 -5 °. The solution was evaporated to 12 ml. in vacuo at 30° 
using a rotary evaporator, then benzene (50 ml.) was added. The 
benzene solution was washed with water followed by potassium 
bicarbonate solution and saturated salt solution, the benzene 
solution was dried with magnesium sulphate then evaporated to 
dryness at 40° in vacuo. The crystalline hydroperoxide (88) which 
remained was not purified further but was immediately acetylated. 
The crude hydroperoxide was dissolved in pyridine (4 ml.) and 
acetic anhydride (4 ml.) at 20 °. After 4 hours more. pyridine 
(4 ml.) was added and the solution was poured onto crushed ice. 
The mixture was stirred and crystallisation commenced, the crystals 
were filtered off, washed well with water and dried in vacuo (1.7 g.). 
The hydroperoxide diacetate (89) was not purified further but 
was reacted directly with base. The crude hydroperoxide diacetate 
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(1.7 g.) was dissolved in dioxan (40 ml.), trimethylamine (4 ml.) 
and water (1.2 ml.). The solution was refluxed for one hour then 
evaporated to 10 ml. in vacuo. The solution was acidified with 
dilute hydrochloric acid then the steroid was extracted with ether. 
The ethereal solution was washed successively with water, sodium 
bicarbonate solution and saturated salt solution, dried with 
magnesium sulphate and evaporated to dryness. The residue was 
chromatographed on alumina (30 g.); elution with ether gave mixed 
fractions containing some saturated 20- ketone ( 1700 cm. -1 max ), 
further elution with ether- chloroform (4:1) gave crystalline 
31,18- diacetoxy -l7- hydroxyandrost -5 -ene (90). This material was 
recrystallised from methanol to give the pure diacetate (90) (580 
mg.) m.p. 142 -144 °; [all) -40° (c 0.1); Z) max.1740, 1240, 1034 
and 819 cm.; n.m.r. 8.96 (C -19 methyl), "r 7.97 (3- acetate methyl), 
T7.83 (18- acetate methyl), T-5.75 (C -18 methylene) and-i4.65 
multiplet (6H). (Found: C, 70.4; H, 8.7. 0231-13405 requires 
C, 70.7; H, 8.8;x) . 
3R, 18- Diacetoxyandrost- 5- en- 17-one (91).- 33,18- Diacetoxy -1713- 
hydroxyandrost -5 -ene (90) (540 mg.) in acetone (80 ml.) was cooled 
to 2° with ice. 8N,Chromic acid reagent121 
(4 ml.) was added 
slowly, keeping the temperature below 40; stirring was continued 
for 20 minutes at 2 -5 °. Methanol (10 ml.) was then added and the 
steroid was extracted into ether. The ethereal solution was 
washed with sodium bicarbonate solution and saturated salt solution, 
dried with magnesium sulphate and evaporated to dryness. The 
residue was recrystallised from aqueous methanol to give 3p,18- 
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diacetoxyandrost- 5- en- 17-one (91) (450 mg.) m.p. 150 -153 °; 
[a]i) -15° (c, 0.1); max.1738, 1378, 1236, 1037 and 908 cm -1; 
n.m.r. ' 8.94 (C -19 methyl), Z 7.98 (3f- acetate and 18- acetate 
methyls), ¿ 5.74 doublet, J =3.5 c.p.s., (18- methylene), 1 4.62 
multiplet (6H). (Found: C, 71.0; H, 8.5. C23H3205 requires 
C, 71.1; H, 8.3%). 
31,18- Dihydroxyandrost- 5- en- 17-one (92).- 3p,18- Diacetoxyandrost - 
5-en-17-one (91) (275 mg.) was dissolved in methanol (86 ml.) at 
o warf 
45 ; k(10 ml.) and concentrated hydrochloric acid (4 ml.) were 
added and the solution was allowed to stand at 45° for 16 hours. 
Water (30 ml.) was added and the solution was evaporated to 40 ml. 
in vacuo at 45° on a rotary evaporator. The crystals which 
formed during this evaporation were filtered off, washed well with 
50% aqueous methanol and dried in vacuo. The material was re- 
crystallised from aqueous methanol to give 3ß,l8- dihydroxyandrost - 
5 -en -17 -one (92) (190 mg.) m.p. 208 -213° (with slight decomposition); 
[a]D +9° (c 0.4); P max. (nujol) 1739, 1054, 997 and 945 cm 71; 
n.m.r. ' 8.98 (C -19 methyl), i 5.96 broad peak (C -18 methylene) 
7,5.17 multiplet, 1 proton, (unassigned), 't 4.56 multiplet (6H). 
(Found: C, 74.8; H, 9.4. C19H2803 requires C, 75.0; H, 9.3 ) 
3R- Hydroxy -18- nor -13a- androst- 5 -en -17 -one (93).- 3fB,18- Dihydroxy- 
o 
androst- 5 -en -17 -one (92) was heated at 230 in a sublimation 
apparatus under a pressure of .01 mm. The product which sublimed 
was resublimed, then removed from the sublimation apparatus and 
weighed (80 mg.), the material was then recrystallised from 
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aqueous ethanol to give 3ß- hydroxy -18- nor -13a- androst- 5 -en -17 -one 
(22 mg.) m.p. 150 -156 °; [a]D -179° (c 0.05) (methanol); max. 
1740 and 1063 cm71; n.m.r. 1 9.15 (C -19 methyl), z 6.5 broad 
multiplet (3a H), z 4.61 multiplet (6H); o.r.d. (methanol, c 0.05) 
20 °C. [4.] 589 -450 °, E] 313 -4360 °, [t] ?80 +872° and [ +] ^35 -2300 °. 
An analytical sample was recrystallised from methanol m.p. 161 -164 °. 
(Found: C, 78.7; H, 9.4. C18H2602 requires C, 78.8; H, 9.55). 
The reaction of 3ß 18 -dih drox androst- 5- en- 17-one with base. - 
3p,18 Dihydroxyandrost- 5 -en -17 -one (20 mg.) was dissolved in 
methanol (20 ml.) and powdered potassium hydroxide (10 mg.) was 
added. The mixture was stirred overnight. The steroid was 
recovered by an ether extraction and the ethereal solution was 
evaporated to dryness. The material did not crystallise well 
but a thin layer chromatogram showed one major spot. The reten- 
tion time of the major component was identical to the retention 
time of 3ß hydroxy-l8- nor -l3a- androst- 5 -en -17 -one prepared above 
(RD = 0.94). 
- 102 - 
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